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ABSTRACT 
The emergence of new diseases and drug resistant pathogens coupled with the side effects 
presented by conventional or synthetic drug use calls for the discovery of new antibiotics and 
chemotherapeutics.  Pseudomonas aeruginosa is a multifaceted Gram-negative opportunistic 
pathogen which is responsible for ten percent of all hospital infections. This, therefore, directed 
the search for novel bioactive molecules with new targets from previously understudied 
sources.   
Plants have bioactive compounds that have been used for traditional healthcare for thousands 
of years.  In the interest of plant preservation, the focus has shifted to include the plant 
microbiome; interestingly, not only were the plants themselves producing the bioactive 
metabolites but also their associated microbiome.  The focus of this study was to screen and 
determine the optimum time to produce anti-Pseudomonas aeruginosa metabolites, to purify 
the compounds of interest and characterise them.  Forty-five endophytic fungi were grown in 
solid substrate fermentation on rice to produce extracts of varying ages (one week to four 
weeks).  
Thin layer chromatography (TLC) coupled with bio-autography revealed that the anti-P. 
aeruginosa compound was produced after three weeks.  Average zones of inhibition of 40.33, 
20.33 and 22 mm were obtained using the Kirby-Bauer disc diffusion assay. All rows A, B, C 
and D show very strong activity as the MICs of the extracts were 156.5 µg/mL, 39.06 µg/mL, 
78.73 µg/mL and 19.53 µg/mL for T1, T2, T3 and T4, respectively. Thin layer chromatography 
was conducted, and optimum separation was observed using hexane: ethyl acetate (60:40, v/v).  
Fractionation was carried out using a silica gel column with six different ratios of a hexane: 
ethyl acetate solvent system.  The first round of purification resulted in twenty-seven fractions 
with five fractions having similar TLC profiles.  These fractions were combined and subjected 
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to a second round of purification that gave three fractions. One fraction was observed to have 
good anti-P. aeruginosa activity and acceptable purity levels after nuclear magnetic resonance 
spectroscopy. Compound one, a dilactone (3a,10b-dimethyl-1,2,3,3a,5a,7,10b,10c-octahydro-
5,8-dioxa-acephenanthrylene-4,9-dione, molecular formula C16H18O4) was isolated as a white 
solid from the extract of the fungus Neofusicoccum luteum. This compound was previously 
isolated from the fungus Oidiodedron griseum. The relative configuration of the compound 
was confirmed by X-ray crystallography. Although the isolated compound is not novel, its 
ability to inhibit the growth of P. aeruginosa is new. This suggests that known compounds 
need to be screened across a wide range of pathogens and organisms to determine potential 
activity. 
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
 
1.1 INTRODUCTION 
In the world today, modern medicine is being used to treat the range of diseases and infections 
of individuals, with varying rates of success. In addition, preventative measures such as 
improved sanitation, better living conditions and clean water practises are being implemented 
to reduce the risk of such infections. Despite these improvements, numerous disease-causing 
pathogenic microbes are becoming more resistant to antimicrobial chemicals.  The drug 
development rate is slower than the rate of microbial resistance, which is proving to be 
challenging (Gabriel and Olubunmi, 2009). The most encountered problem when treating 
microbial infections is antimicrobial resistance (Zankari et al., 2017).  
The appearance of new diseases and drug tolerant pathogens, together with the side effects 
caused by conventional drug use demands that new drugs be discovered.  Over the past decade, 
increasing outbreaks caused by methicillin resistant Staphylococcus aureus (MRSA), 
Enterococcus sp. that are vancomycin resistant (VRE), extended spectrum beta lactamase-
producing (ESBL) Escherichia coli and Pseudomonas aeruginosa have been reported 
(Hancock and Speert, 2000; Hirsch and Tam 2010). There is thus, an urgent need for novel 
antibiotics with new targets that may prove efficacious in treating infections caused by these 
resistant microbes. Several candidate drugs, namely, quinupristin/dalfopristin and the 
oxazolidinone linezolid, have been tested and are reputed to be effective in treating vancomycin 
resistant Enterococcus faecium (VREF) and skin infections caused by MRSA, Streptococcus 
pyogenes and other Gram-positive bacteria (Kraft et al., 2014).  However, these new antibiotics 
fail or have little activity against Gram-negative bacteria (Wright et al., 2017). This is the main 
hurdle that needs to be overcome in order to combat the growing resistance of P. aeruginosa.
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1.2. Pseudomonas aeruginosa 
Pseudomonas aeruginosa is aerobic, Gram-negative and rod shaped.  Due to its ability to cause 
diseases in immuno-compromised patients, it is referred to as an opportunistic pathogen. It is 
a versatile microbe able to tolerate low oxygen conditions, survive in nutrient deficient 
environments and tolerates a temperature range from 4-42°C.  It is a multifaceted pathogen 
which is able to cause a wide range of infections and is the main cause of opportunistic 
nosocomial infections, causing approximately 10% of hospital infections. Chronic lung 
infections which lead to the death of patients with cystic fibrosis are mainly caused by this 
pathogen (Lutz and Lee, 2011).   
The National Nosocomial Infection Surveillance done in South African hospitals over three 
decades showed P. aeruginosa to be the eighth most isolated pathogen from blood (3.4%) and 
the third most common cause of urinary tract infections (16.3%) (Hancock and Speert, 2000; 
Hirsch and Tam, 2010).  The general prevalence of P. aeruginosa infections remained constant 
from 1986 to 2003. However, the incidence of resistant strains increased drastically in 2003.  
The rate of resistance of P. aeruginosa to imipemen increased by 15.9% in 2003 and by 20% 
to quinolones and third generation cephalosphorins (Hirsch and Tam, 2010).  Likewise, a study 
on Intensive Care Unit patients in South African hospitals reported a notable increase in P. 
aeruginosa strains resistant to at least three out of four antibiotics (multidrug resistant, MDR) 
(Nathwani et al., 2008).  
Pseudomonas aeruginosa is highly adaptive and this quality is proved by its ability to survive 
in the highly stressful and hostile environment found within a lung with cystic fibrosis (CF) 
(Minstanley et al., 2016). Nitrosative, osmotic and oxidative stresses are some examples of 
stresses found within CF infected lungs (Silva et al., 2010).  Phenotypic analysis of isolates 
found within these infected lungs show an accumulation of auxotrophic mutations, conversion 
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of isolates from motile to sessile and the formation of mucoid colonies. The above-mentioned 
adaptations all provide protection to P. aeruginosa from antibiotics and host responses. Other 
adaptations the emergence of hypermutators (Minstanely et al., 2016). Since CF patients are 
usually under long treatment with antimicrobials, the fast emergence of antimicrobial 
resistance is frequently encountered. Therefore, screening, purifying and characterising 
bioactive products with anti-P. aeruginosa activity is important, especially in South Africa 
where there is a high number of immuno-compromised patients. 
 
1.2.1 Pseudomonas aeruginosa biofilms 
Pseudomonas aeruginosa is considered an important plant and human pathogen due to its 
ability to produce various virulence factors (Epps and Walker, 2006).  Apart from this, the 
ability of P. aeruginosa to form biofilms on many surfaces makes antibiotic treatments 
ineffective and thus promotes chronic infectious diseases.  Biofilm formation is a continuous 
cycle, where organised bacterial communities are enclosed in a matrix of extracellular 
polymeric substances (EPS) which holds microbial cells together and allows adherence to 
surfaces (Rasamiravaka et al., 2015).  Extracellular polymeric substances are composed mainly 
of exopolysaccharides, extracellular DNA (eDNA), biomolecules and polypeptides that form 
a highly hydrated mixture that is implicated in the overall structure and architectural strength 
of the biofilm (Ding et al., 2016).  
Varying biofilm phenotypes can be expressed, depending on the strain of P. aeruginosa and 
the nutritional conditions.  For example, in glucose limiting conditions, the P. aeruginosa 
PAO1 biofilm life cycle can be divided into five phenotypic stages (Figure 1.1).  The reversible 
attachment of planktonic bacterial cells onto a growth surface begins this cycle (Figure 1.1 a, 
Stage I), irreversible attachment of bacteria which form microcolonies in the EPS matrix 
4 
 
continues this process (Figure 1.1 b, Stage II). Gradually, bacterial microcolonies expand and 
their individual contributions lead to a more structured phenotype with noncolonised space 
(Figure 1.1 c, Stage III).  Later, free spaces within the biofilm become filled with bacteria and 
covers the whole surface (Figure 1.1 d, Stage IV). Three-dimensional communities grow as 
observed in Figure 1.1, Stages III and IV.  Figure 1.1 e, Stage V, shows the last stage which is 
bacterial conversion from non-motile to planktonic form, in order to spread and inhabit other 
surfaces (Nikolaev and Plakunov, 2007; Flemming and Wingener, 2010; Rasamiravaka et al., 
2015).  
 
Figure 1.1: Biofilm lifestyle cycle of P. aeruginosa PAO1 grown in glucose minimal media. In stage I, 
planktonic bacteria initiate attachment to an abiotic surface, which becomes irreversible in stage II. 
Stage III corresponds to microcolony formation. Stage IV corresponds to biofilm maturation and growth 
of the three-dimensional community. Dispersion occurs in stage V and planktonic bacteria that are 
released from the biofilm colonise other sites (Rasamiravaka et al., 2015). 
 
1.2.2 Pseudomonas aeruginosa biofilm formation as a resistance mechanism 
Antimicrobial resistance is the natural response of bacteria to antibiotic exposure.  It can come 
about by spontaneous genetic mutations, be intrinsic to a bacterium, or be linked to horizontal 
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gene transfer (Sherrard et al., 2014).  Pseudomonas aeruginosa displays resistance to numerous 
antibiotics due to its ability to form biofilms.  Figure 1.2 depicts the mechanisms of resistance 
to antibiotics which is largely due to a reduced activity of antibiotics inside the biofilm 
(Sherrard et al., 2014).  It is hypothesised that antibiotics do not penetrate the biofilm (Gomes 
et al., 2012).  This could be because it acts as a physical barrier which keeps antibacterial agents 
out of the biofilm (e.g. aminoglycosides) preventing their diffusion (Figure 1.2) (Sherrard et 
al., 2012; Gupta et al., 2015). This interaction also prevents the passage of antibiotics into the 
biofilm base, for example, in cystic fibrosis patients, steep oxygen slopes and oxygen deprived 
cavities form inside the cystic fibrosis mucus layer due to increased oxygen utilisation together 
with poor oxygen diffusion within the mucus.   
 
 
 
Figure 1.2: Mechanisms of resistance in multidrug resistant P. aeruginosa (Sherrard et al., 2014). 
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Hill and co-workers (2005) revealed aerobically grown P. aeruginosa to be more susceptible 
to β-lactam, aminoglycoside and colistin antibacterial agents than anaerobically grown P. 
aeruginosa (Hill et al., 2005). Furthermore, since aminoglycoside antibiotics need oxidative 
phosphorylation in order to enter bacterial cells, a low oxygen concentration inactivates these 
antibiotics (Schaible et al., 2012).  In addition, hypoxia is reported to increase efflux pump 
expression in P. aeruginosa and this causes increased resistance to cephalosporin and penicillin 
antimicrobials (Schaible et al., 2012).  Biofilm formation in cystic fibrosis is a symptom of 
chronic airway infection. Bacteria growing in biofilms are buried in an exopolymeric matrix 
(which includes exopolysaccharide, protein and DNA) that have been shown to be more 
resistant when compared to planktonic cells (Lutz and Lee, 2011; Sherrard et al., 2014).  A sub 
population of bacteria in the biofilm may adapt a protective phenotype and become persistor 
cells.  Figure 1.3 summarises the different types of cells found within a biofilm. 
 
Figure 1.3: Three mechanisms of antibiotic resistance in biofilms (Stewart and Costerton, 2001). 
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1.2.3 Pseudomonas aeruginosa virulence factors 
Pseudomonas aeruginosa has five known virulence factors: (i) flagella and type 4 pili, (ii) type 
3 secretion system, (iii) quorum sensing and biofilm formation, (iv) lipopolysaccharides and 
(v) proteases (Figure 1.4).  Each P. aeruginosa cell possesses several type 4 pili and a single 
polar flagellum that can initiate an inflammatory response.  During infection, the bacterium can 
attach to host epithelial cells by binding its flagellum to the asialyated glycolipid asialoGM1 
which can elicit a strong NFjB-mediated inflammatory response via signalling through TLR5 
and a caspase-1-mediated response through the Nod-like receptor, Ipa (Mena et al., 2008).  
Mutants which don’t have flagella cannot elicit an inflammatory response.  Thus, flagella are 
believed to be required to establish an infection.  Type 4 pili are the most important attachment 
apparatus. Pili can also facilitate aggregation, causing the bacteria to form microcolonies on 
host target tissues, effectively forming a dense packing of bacteria in one location.  They protect 
the bacteria from antibiotics and the host immune system (Williams et al., 2010).  
Pseudomonas aeruginosa microcolonies are highly implicated in chronic cystic fibrosis.  Pilin-
deficient mutants and those that do not display twitching motility, show reduced virulence in 
various models (Mena et al., 2008). Type 3 secretion systems (T3SS) are common among 
several pathogenic Gram-negative bacteria as a way of injecting toxins directly into host cells.  
The T3SS in P. aeruginosa has four effectors which were identified as – ExoY, ExoS, ExoT, 
and ExoU – far fewer than many other well-characterised T3SS (e.g. Salmonella enterica SPI-
1 has 13, Shigella sp. have 25) (Hauser, 2009).  The T3SS of P. aeruginosa is encoded by 36 
genes on five operons.  The entire system is transcriptionally controlled by ExsA, a member of 
the AraC family of transcriptional activators (Yahr and Wolfgang, 2006).  Nearly all strains 
express one of the two major exotoxins, exoU or exoS, but very rarely both.  
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ExoS is bifunctional, including both N-terminal GTPase-activating protein activity and C-
terminal ADP ribosyltransferase (ADPRT) activity (Otter et al., 2011).  Both activities are 
linked to the actin cytoskeletal organisation, although the ADPRT activity is understood to play 
a larger part in pathogenesis.  ExoU is a phospholipase and is estimated to be 100 times more 
potent a cytotoxin than ExoS and causes rapid death of host eukaryotic cells due to loss of 
plasma membrane integrity consistent with necrosis (Mena et al., 2008).  Lipid A can be 
sequentially bound by host cell coreceptors MD2 and CD14 leading to activation of the TLR4 
to NFjB signalling pathway and triggering the production of pro-inflammatory cytokines and 
chemokines, inflammation, and over time endotoxic shock (Bardoel et al., 2011).  Alkaline 
protease is a type 1 secreted zinc metalloprotease that is known for its degradation of host 
complement proteins and host fibronectin.  In addition, alkaline protease has been shown to 
interfere with flagellin signalling through host TLR5 by degrading free flagellin monomers and 
thereby helping P. aeruginosa to avoid immune detection (Gellatly and Hancock, 2013). 
 
 
Figure 1.4: Virulence factors produced by P. aeruginosa (Gelattly and Hancock, 2013). 
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The prominence of P. aeruginosa as a pathogen is due to its high intrinsic resistance to 
antibiotics (Table 1.1), to the point that the efficacy of even the newest antibiotics is 
significantly altered (Lutz and Lee, 2011).  This, therefore, directed the search for novel 
bioactive molecules from previously unexplored sources.  
Table 1.1: Pseudomonas aeruginosa resistance mechanisms towards antibiotics (Hancock and Speert, 
2000) 
Class  Agents Mechanism of action 
Penicillin Ticarcillin, 
Carbenicillin, 
Piperacillin 
Depression of chromosomal β-lactam.  Overexpression of 
the MexAB-OprM multidrug efflux pump due to a NalB 
mutation.  Specific plasmid-mediated β-lactamases. 
Cephalosporin Ceftazidime  
Cefoperazone 
Cefepime 
Cefpirome 
 
Depression of chromosomal β-lactam.  Overexpression of 
the MexAB-OprM multidrug efflux pump due to a NalB 
mutation.  For the fourth generation cephalosporins 
cefepime and cefpirome, overexpression of the MexCD-
OprJ multidrug efflux pump due to an NfxB mutation.  
Aminoglucoside Gentamicin 
Tobramycin 
Amikacin 
Overexpression of the MexXY efflux pump in 
impermeability type-resistance due to a mutation in the 
regulatory gene MexZ. Plasmid-mediated production of 
modifying enzymes. 
Quinolones Ciprofloxacin 
 
Target site mutations in the GyrA (or sometimes the GyrB) 
topoisomerase subunit; Overexpression of multidrug 
efflux pumps due to NalB, NfxB or NfxC mutations. 
Polymixin Colistin 
 
Outer membrane LPS changes due to PhoP/PhoQ 
regulatory mutations. No evidence this occurs in the clinic. 
Carbepenem Imipenem 
Meropenem 
Loss of specific outer membrane porin channel, OprD; 
Reduction in levels of OprD due to an NfxC mutation that 
also upregulates multidrug resistance due to MexEF-
OprN. For meropenem overexpression of the MexAB-
OprM multidrug efflux pump due to a NalB mutation. 
 
1.3 MEDICINAL PLANTS 
Plants contain bioactive compounds which have been used for traditional healthcare for 
thousands of years. The ethno-pharmaceutical knowledge of Traditional Chinese medicine 
includes over 5000 species (Miller et al., 2012). Plants play a significant role in drug 
development and discovery, worldwide. From 1981 to 2010, 26% of new drugs were natural 
products and this peaked to 50% in 2010 (Newman and Cragg, 2012).  Plants with antibacterial 
properties are of central importance as biological sources of novel active metabolites that may 
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provide a solution to the alarming incidence of antibiotic resistance in clinical strains.  
Medicinal plants offer a promising source for such drugs. These plants are reservoirs of 
compounds that can be used in drug development (Hassan, 2012).   
Cassia fistula is a medicinal plant that produces bioactive secondary compounds, which are 
currently being used as dietary supplements, medicines and other useful commercial products 
(Kadhim et al., 2016).  Investigations into this plant were prompted by their use in traditional 
medicine which has been passed down from generation to generation (Mishra and Behal, 2010).  
Cassia fistula has been reported to contain flavonoids, alkaloids, tannins, terpenes, and 
glucosides (Ali, 2014). These compounds are responsible for the antibacterial activity of the 
plant and form the basis for its use in the manufacture of antibiotics.  
The combined effects of the secondary metabolites of papaya impart medicinal properties that 
prevent heart disease, colon cancer and strokes (Aravind et al., 2013).  Recently, the aloe plant 
was discovered to possess antiseptic properties along with other properties including laxative 
and anti-inflammatory skin agent which clears acne and soothes eczema (Mavintha and Bidya, 
2014).  Plants with anti-inflammatory properties have been reported to display antimicrobial 
activity too. 
Plant essential oils are a very diverse group of secondary metabolites that are potentially useful 
sources of antimicrobial compounds.  Many studies have reported on the antimicrobial activity 
of essential oils (Soković et al., 2010; Moussaoui and Alaoui, 2016).  According to Moreti 
(2004), essential oils, unlike antibiotics, consist of numerous molecules that bacteria cannot 
gain resistance towards. These essential oils they are known for their potent antiviral, anti-
fungal, anti-inflammatory and antibacterial effects.  The combination of essential oils with 
antibiotics may lead to new ways to treat infectious diseases.  Many researchers have studied 
the synergistic effects resulting from the combination of antibiotics with different plant extracts 
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which reduced bacterial resistance to drugs (Ghaleb and Mhanna, 2008; Stefanovic and Comic, 
2012; Moussaoui and Alaoui, 2016).   
 
1.3.1 Kigelia africana 
Taking all medicinal plants in Africa into consideration, the most widely distributed is Kigelia 
africana (Figure 1.5).  K. africana is found in tropical regions including Central, South and 
West Africa (Saini et al., 2009; Oyedeji and Bankole-Oje, 2012).  It is referred to as the sausage 
tree due to the big fruit that it bears (0.6 m in length and 4 kg weight) (Saini et al., 2009; Azu 
et al., 2010).   
    A                  B       C                             D 
 
     Tree                                               Leaves                                    Flower                           Fruit 
Figure 1.5: Kigelia africana. A, B, C, D showing the tree, leaves, flower and fruits, respectively (Saini, 
2009). 
 
All parts of the plant have been reportedly used to treat illnesses (Idris et al., 2013).  In rural 
regions of Africa, various forms of the plant are believed to cure a large number of illnesses.  
These include topical applications for fungal infections, psoriasis, eczema and boils (Atawodi 
et al., 2017).  This plant has also been administered internally for the treatment of malaria, 
toothache, pneumonia, ringworm, tapeworm and diabetes (Azu et al., 2010).  During famine in 
Malawi, the seeds were roasted and eaten (Azu, 2013).  In the Zambezi Valley, the Tonga 
women apply cosmetic creams of K. africana to their faces to maintain and ensure blemish-
free faces (Saini et al., 2009).  Other applications of K. africana include a preparation of the 
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flowers for application on breasts of lactating females to increase the flow of milk (Atawodi et 
al., 2017).  K. africana extracts are used to treat toothaches and sores associated with diabetes; 
this prompted the study of this plant for its potential to produce antibacterial compounds (Siani 
et al., 2009). 
 
1.3.2 Kigelia africana metabolites 
Several metabolites have been extracted from various parts of this plant.  These include the 
furanone derivative 3-(2-hydroxyethyl)-5-(2-hydroxypropyl)-dihydrofuran-2-(3H)-one and 
four irridiods (7-hydroxy viteoid II, 7-hydroxy eucommic acid, hydroxy-10-deoxyeucommiol 
and 10-deoxyeucommol) (Akanni et al., 2017).  A novel phenylpropanoid derivative was 
isolated from the fruit and identified as 6-p-coumaroyl sucrose, as well as ten known 
phenylpropanoids and phenylethanoids and a flavonoid glucoside.  Kigelin (Figure 1.6), the 
major constituent in K. africana was also isolated in 1971 by Govindchari et al. (1971).  
 
Figure 1.6:  Structure of kigelin (Idris et al., 2013). 
 
Kigelin is a 8-hydroxy-6,7-dimethoxy-3-methyl-3,4-dihydroisocoumarin. Other compounds 
such as 6-methoxymethymellein, stigmasterol, lapachol, β-sitosterol, 3-dimethyl kigelin, 
kigelinone, naphthaquinones, dehydro-α-lalachone and isopinnatal, isolated from various parts 
of the plant were found to impart antibacterial and antifungal activity (Grace et al., 2002; 
Gabriel and Olubumni 2009; Idris et al., 2013). Other properties of the plant include 
antiprotozoal and anti-amoebic activity (Oyedeji and Brankole-Oje 2012).  Table 1.2 depicts 
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some classes of secondary metabolites isolated from K. africana and their biological activities 
based on studies by Akunyili et al. (1991), Kwo and Cracker (1996), Grace et al. (2002) and 
Saini et al. (2009).  
 
Table 1.2: Pharmacological activities of different phytoconstituents of Kigelia africana 
Activity Irridiods Naphthoquinone Meroterpenoid 
naphthoquinones 
Coumarin 
derivatives 
Lignans Sterols Flavonoids 
Anticancer + + + + + + + 
Anti-
mollusidal 
+ - - - - - + 
Against 
syphilis and 
gonorrhea 
+ + - - - + + 
Antidiarrheal + - - - - - + 
Antiulcer + - - - - - + 
Antifungal - - + - + + + 
Antimalarial - - + - + - - 
Anti-
inflammatory 
+ + + - - + + 
Antibacterial + + + - + + - 
Against 
postpartum 
haemorrhage 
+ - - + - + - 
Anti-
Pneumonia 
+ - - - - + + 
Keys: -Not active; + active 
In the interest of plant preservation, the focus has shifted to include the plant microbiome.  
Studies have surprisingly shown that not only were the plants themselves producing the 
bioactive metabolites, but their associated microbiomes were as well (Jalgaonwala et al., 2011). 
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1.4 ENDOPHYTES  
Investigations on the same plant species located in different geographical regions/countries 
have shown that they carried different active metabolites suggesting that the bioactive 
secondary metabolites are produced by endophytic microorganisms. Endophytes are 
microorganisms (including Actinomycetes, fungi and bacteria) which colonise plants without 
any symptoms (De Bary, 1886 cited by Sadrati et al., 2013; Kusari et al., 2013).  Mutualism or 
asymptomatic colonisation has been attributed to a balance of antagonism between the host 
defence responses and the virulence factors of the endophytic microorganism by Kusari and 
co-workers (2013) (Figure 1.7).  Figure 1.7 also shows that the presence of certain 
environmental factors may cause a shift from mutualism to pathogenesis.  
 
Figure 1.7:  Interactions between endophyte, parasites and host plants (Kusari et al., 2012). 
 
Endophytes and plants produce similar metabolites, probably due to the endophyte and plants 
coevolving over several millennia (Kusari et al., 2012).  The plant provides shelter and 
nutrients and in return the endophytes protect the plant from biotic and abiotic stresses.  An 
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early report of this by Webber (1981), showed that the endophytic fungus, Phomopsis oblonga, 
provided protection to elm trees against the beetle, Physosnemum brevilineum. This endophytic 
fungus reduced the spread of the causal agent of Dutch elm disease by producing toxic 
repellents against P. brevilineum (Kusari et al., 2013).  Figure 1.8 depicts this protection by 
endophytic fungi.  It was later proven that endophytic fungi belonging to the family Xylariacea 
could synthesise toxic secondary metabolites that affect beetle larvae (Claydon et al., 1985; 
Suryanarayanan, 2017).   
 
 
Figure 1.8: Strategies employed by endophytic fungi to protect plants against insects (Kusari et al., 
2013). 
 
Due to the emergence of drug resistant superbugs, there is an ever-increasing need for obtaining 
new compounds which are aimed at alleviating illnesses caused by pathogens (Sadrati et al., 
2013).  The ability of older types of antimicrobial agents to cure diseases continues to decrease.  
In addition, synthetic drugs threaten the environment and have serious side effects (Clay, 
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2014).  Removal of these agents creates a gap which needs to be filled by new compounds with 
the ability to control human pathogens.  There is an immediate need to find and produce 
environmentally safe drugs (Sadrati et al., 2013).  
Research conducted by Stierle et al. (1993; 1995) reporting on the discovery of the endophytic 
fungus, Taxomyces andreane, which produces Taxol®, an anticancer drug, directed intense 
attention towards endophytic fungi (Das et al., 2017). This formed the basis and major 
motivating factor towards the study of fungal endophytic bioactive molecules. They are 
considered excellent reservoirs of therapeutically active compounds due to their genetic 
diversity (Darsih et al., 2017).  Endophytic fungi have been found to be present in all plants 
studied to date and are thought to be ubiquitous in plants (Huang et al., 2001; Kirk et al., 2001; 
Strobel and Daisy 2003; Jalgaonwala et al, 2011).   
It is estimated that 1.5 million endophytic fungi live within plants and lichens (Huang et al., 
2008). The incidence of endophytes within plant tissue appears to be environmentally 
influenced.  Arnold and Lutzoni (2007) showed that the incidence of infection by endophytes 
approached 100% in plants situated in tropical regions; this incidence is exponentially higher 
than in plants found in polar regions.  Rosa et al. (2009) later confirmed these findings.    
Most endophytic fungi belong to the phylum Ascomycota, while some belong to the phyla 
Basidiomycota and Zycomycota (Huang et al., 2001).  It was shown that the presence or 
absence of endophytic fungi can affect plant structures and communities.  Arbuscular 
mycorrhizal fungi grow deep into the soil facilitating better uptake of nutrients from the soil, 
especially the roots (Cosme et al., 2018).  This improves plant growth and survival allowing 
taller and stronger plants.  The presence of root endophytes.  Thus, plants that grow near plants 
with root endophytic fungi also reap the benefits of more nutrient availability (Allen et al., 
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2018).  The whole plant community benefits. These fungi also change the internal morphology 
of plant tissue by forming arbuscules within the plant tissue.  
Investigations into the genomes of plants and associated endophytes have revealed that they 
contain conserved gene clusters that have co-evolved during their long association reportedly 
dating back 400 million years (Chagas et al., 2018). These gene clusters encode novel 
secondary metabolites that may have potential medicinal applications (Lahn et al., 2017).  
Much work has been conducted to elucidate the genomes of several endophytic fungi. Wang 
and co-workers (2001) sequenced the Pestalotiopsis fici genome and found that it harboured 
numerous secondary metabolite synthesis genes: 27 polyketide synthases (PKS), 12 non-
ribosomal peptide synthases (NRPS), 5 dimethylallyl tryptophan synthases, 4 putative PKS-
like enzymes, 15 putative NRPS-like enzymes and 15 terpenoid synthases.  These core 
enzymes are distributed into 74 different secondary metabolite clusters.  Secondary metabolites 
are synthesised when precursor metabolites are limited during primary metabolism (Figure 1.9) 
(Nielsen and Nielsen, 2017).   
 
Figure 1.9: Biosynthesis of secondary metabolites from precursors of the central carbon metabolism. 
PPP: Pentose Phosphate Pathway. ETC: Electron Transport Chain. TCA: Tricarboxylic acid. AAs: 
amino acids (Nielsen and Nielsen, 2017). 
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These precursors are predominantly amino acids or short chain carboxylic acids, backbone 
enzymes like PKSs, DMATSs, NRPSs or TCs link them together.  The resulting oligomers are 
chemically modified by enzymes which are controlled by the usual transcriptional regulators 
as the backbone enzymes. The characteristic trait of genes involved in the secondary metabolite 
pathways is that they cluster in the chromosome in biosynthetic gene clusters (BCGs) (Nielsen 
and Nielsen, 2017).  The ability to produce secondary metabolites is common to most living 
organisms but it is unevenly distributed.  In known antimicrobial compounds (about 22 500 in 
total), 45% are produced by actinomycetes, 38% by fungi and 17% are from bacteria.  In 
addition, even with this abundance of compounds, it is estimated that only 100 are used for 
human therapy, with most of these being produced by actinomycetes.  However, it must be 
acknowledged that aside from penicillin, other fungal secondary metabolites have been of 
pharmaceutical use; these include, but are not limited to, griseofulvin, statins and mycophenolic 
acid. 
Natural products produced by endophytic microbes are observed to inhibit and kill a variety of 
harmful pathogens, including bacteria, fungi and protozoans (Darsih et al., 2017). These 
products are also known to deter herbivores (Jalgoanwala et al., 2011, Das et al., 2017).  
Cryptosporiopsis quercina is a fungus from which a unique antifungal compound named 
cryptocandin was extracted.  This compound contains known amino acids and one new amino 
acid (3-hydroxy-4-hydroxy methyl proline) (Nandini et al., 2018).  Cryptocandin has shown 
very efficient activity against human fungal pathogens, namely, Trycophyton spp. and Candida 
albicans.  Antifungal activity by cryptocandin was also observed against Botrytis cineria and 
Sclerotinia sclerontiorum which are plant pathogens.  
The study into endophytic fungi is only just beginning as only a tenth of fungal species have 
been isolated out of the approximately 1.5 million thought to exist. The study of the endophytes 
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of K. africana are still in the developmental stages as little is known about them.  Idris et al. 
(2013) isolated endophytic fungi from K. africana and screened extracts produced by these 
fungi for antibacterial activity.  The seven endophytic fungi isolated were identified to be 
Aspergillus sp., Aspergillus flavus, Cladosporium sp., Curvularia lunata and three unknown 
fungi.  The Aspergillus sp., Cladosporium sp. and two of the unknown fungi displayed 
antibacterial activity.  These results, therefore, suggest that endophytic fungi from K. africana 
have the potential to produce useful bioactive compounds with antimicrobial activity. 
 
1.5 SEPARATION, PURIFICATION AND CHARACTERISATION OF FUNGAL 
BIOACTIVE EXTRACTS 
Natural products, such as plant extracts, either as pure compounds or as standardized crude 
extracts, provide unlimited opportunities for new drug discovery because of the unmatched 
availability of chemical diversity (Mahmoudvand et al., 2015).  According to the World Health 
Organization (WHO), more than 80% of the world's population relies on traditional medicine 
for their primary healthcare needs (Oyebode et al., 2016). A summary of the general 
approaches in extraction, isolation and characterisation of bioactive compound from plant 
extracts can be found in Figure 1.10 (Sasidharan et al., 2011). 
 
 
 
 
 
 
Figure 1.10: General approaches in extraction, isolation and characterisation of bioactive metabolites 
(Sasidharan et al., 2011). 
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1.5.1 Thin layer chromatography (TLC) 
Thin layer chromatography (TLC) is a method mainly used in forensic drug chemistry, which 
separates compounds of a drug mixture (Harper et al., 2017).  Forensic laboratories use TLC 
to examine unknown drug mixtures.  In TLC, the mobile phase is a solvent (liquid), and the 
stationary phase is a thin aluminium sheet coated with a thin layer of adsorbent material, 
usually silica gel, aluminium oxide (alumina), or cellulose. The mobile phase transports the 
solute through the stationary phase (Sasidharan et al., 2011).  The speed at which the solute 
move on the TLC plate depends on the strength of the mobile phase as it dissolves the solute 
and migrates it up the plate (Klimek-Turek et al., 2016), together with the sorbent as it pulls 
the solute out of solution and back into the sorbent.  The molecules move via a stop and go 
motion due to the solute being absorbed and desorbed repeatedly (Santiago and Strobel, 2013).  
A small fraction of the solute moves at a given time with each spot travelling a certain distance.   
Substances that are strongly attracted to the solid layer move slowly because they spend more 
time in the sorbent and fast-moving compounds have a low affinity for the stationary phase and 
a high affinity for the mobile phase and thus spend more time in the mobile phase. Therefore, 
separation of compounds with varying properties is achieved by exploiting the interactions of 
the solutes with the mobile and stationary phases.  Analysis of this assay entails calculating the 
Rf value and that is the distance migrated by the compound divided by the distance migrated 
by solvent (Kumar et al., 2013) (Figure 1.11). This value gives meaning to TLC as it can be 
compared to the Rf values of known standards. 
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Figure 1.11: Thin layer chromatography (Kumar et al., 2013). 
 
A study by Abok and Manulu in 2017, was conducted to identify phytochemical constituents 
of Syzygium guineense leaf extract.  The bark and leaves of S. guineense are used to treat dysentery, 
wounds, ulcers, tuberculosis and chronic diarrhea. TLC analysis was conducted using hexane and ethyl 
acetate as solvents. Hundred % hexane, hexane: ethyl acetate (2:1) and hexane: ethyl acetate (3:1) were 
used. It was observed that 100% hexane did not resolve the contents, while hexane:ethyl acetate (2:1) 
and hexane: ethyl acetate (3:1) yielded three and seven bands with Rf values 0.13, 0.23, 0.84 and 0.007, 
0.13, 0.23, 0.32, 0.40, 0.54, 0.81 respectively (Abok and Manulu, 2017).    
 
1.5.2 Bio-autography 
Bio-autography enables the localising of antimicrobial activities of an extract on the 
chromatogram, thus it supports the search for new antimicrobial agents through bioassay-
guided isolation (Swapna et al., 2015).  The advantages of the bio-autography agar overlay 
method includes use of small amounts of sample extract and the ability to identify the exact 
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component with antimicrobial activity from the crude sample (Rahalison et al., 1991).  There 
are various methods to TLC bio-autography (direct, contact and agar overlay). Figure 1.12 
represents direct bio-autography which entails the spraying of a 24-hour culture on a dried TLC 
plate, incubating at 37°C for 24 hours and spraying with 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT) as conducted by Samrot et al., 2016. The resultant spots 
(compounds) with antibacterial activity appear clear while the compounds with no 
antimicrobial activity appear green.  The most commonly used dyes are MTT and tetrazolium 
dye.  
 
Figure 1.12: Thin layer chromatography (TLC) and TLC bioautography for antimicrobial activity in 
Acacia sp. (Samrot et al., 2016). 
 
In contact bio-autography, antimicrobial compounds diffuse from a developed TLC plate to an 
agar plate inoculated with the test strains (Sherma, 2008; Dewanjee et al., 2015). The 
chromatogram is placed face down onto the inoculated agar layer for a specific period to enable 
diffusion of the compounds from the TLC plate to the agar plate.  The chromatogram is 
removed, and the agar layer is incubated.  The zones of inhibition on the agar surface, 
corresponding to the spots in chromatographic plates, are indicative of the antimicrobial agents.  
An overall view of contact bio-autography is shown in Figure 1.13. Incubation time for the 
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growth ranges between 16 and 24 hours but it can be reduced to 5–6 hours by 2,3,5-tetrazolium 
chloride (Dewanjee et al., 2015).  
 
Figure 1.13: Schematic diagram indicates the direct bioautographic process (Dewanjee et al., 2015). 
 
Agar overlay is a combination of contact and direct bio-autography.  In this method, the 
chromatogram is covered in a molten, seeded agar medium.  After solidification, incubation 
and staining (usually with tetrazolium dye), the inhibition or growth bands can be seen (Figure 
1.14). 
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Figure 1.14: Schematic diagram of agar overlay bioautography (Dewanjee et al., 2015). 
 
1.5.3 High performance liquid chromatography (HPLC) 
High performance liquid chromatography (HPLC) is a widely used technique for the isolation 
of natural products (Capone et al., 2015).  In order to fully characterise the active entity, natural 
products are often isolated following the biological evaluation of a relatively crude extract.  
The bioactive component is often present only as a minor component in the extract and the 
resolving power of HPLC is well suited to rapidly process multicomponent samples on both an 
analytical and preparative scale (Hayes et al., 2014).   
Gradient elution in which the proportion of organic solvent to water is altered with time may 
be desirable if more than one sample component is being studied and significantly differ from 
each other in retention under the conditions employed (Sasidharan et al., 2011).  Purification 
of the compound of interest using HPLC is the process of separating or extracting the target 
compound from other (possibly structurally related) compounds or contaminants.  Each 
compound should have a characteristic peak under certain chromatographic conditions.  
Identification of compounds by HPLC is a crucial part of any HPLC assay.  In order to identify 
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any compound by HPLC, a detector must first be selected (Hayes et al., 2014).  Once the 
detector is selected and is set to optimal detection settings, a separation assay must be 
developed.  The parameters of this assay should be such that a clean peak of the known sample 
is observed from the chromatograph.  The identifying peak should have a reasonable retention 
time and should be well separated from extraneous peaks at the detection levels which the assay 
will be performed.  UV detectors are popular among all the detectors because they offer high 
sensitivity) and also because majority of naturally occurring compounds encountered have 
some UV absorbance at low wavelengths (Capone et al., 2015) (190-210 nm). Figure 1.15 
shows a summarised illustration of how HPLC components.  
 
 
Figure 1. 15: High performance liquid chromatography system (Czaplicki, 2013). 
Phenolic acids were extracted from the three date varieties and identified by high-performance 
liquid chromatography (HPLC) as described by Mansouri et al. (2005). One hundred grams of  
sample was mixed with 300 mL methanol/water (4:1, v/v) for 5 h at room temperature and with 
continuous agitation. The mixture was then centrifuged for 5 minutes at 6000g and the 
supernatant was evaporated under vacuum at 40 °C. The residue from the evaporation was 
treated with 200 mL of water (pH 2 with HCl) and left to rest for 5 min. The resulting mixture 
was then passed through a glass column (4.6 cm × 15 cm) packed with Amberlite XAD-2 resin 
(Fluka Chemie; pore size 9 nm, particle size 0.3–1.2 mm).  Gallic acid, vanillic acid, coumaric 
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acid and ferulic acid to name a few and the acids were later tested for antioxidant activity 
Kchaou et al., 2016). 
 
1.6 CHARACTERISATION OF ANTIMICROBIAL COMPOUNDS 
Structural determination of compounds uses information from a vast range of spectroscopic 
techniques (Zhang et al., 2018). These include infrared (IR) spectroscopy, nuclear magnetic 
resonance (NMR) spectroscopy, mass spectroscopy (MS) and UV- visible spectroscopy (UV-
Vis) (Altermimi et al., 2017).  Passing electromagnetic radiation through an organic molecule 
that absorbs some of the radiation is the basic principle of spectroscopy. Measuring the quantity 
of absorbed electromagnetic radiation produces a spectrum (Zhang et al., 2018).  The spectrum 
is bond specific and depending on the spectra, the structure of the molecule can be elucidated.  
For structural clarification, scientists use spectra produced from three or four regions, namely 
visible, ultraviolet, infrared and electrical beam (DeVijlder et al., 2018).  
 
1.6.1 Nuclear Magnetic Resonance (NMR) spectroscopy 
Magnetic properties of selected atomic nuclei are what NMR is based on, namely, the nuclei 
of the carbon atom, the hydrogen atom, the proton and an isotope carbon (Vioglio et al., 2018).  
NMR allows researchers to study molecules by noting variances between various magnetic 
nuclei and giving the positions at which, these differences are found within the nuclei of these 
molecules (Hansen et al., 2016).  In addition, it shows the kinds of atoms found in neighbouring 
groups.  In essence, it is able to conclude on the number and type of atoms present in each of 
these environments. 
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1.6.2 Fourier-transform infrared spectroscopy (FTIR) 
When infrared light passes through an organic compound, some of the frequencies will be 
absorbed; however, some are transmitted through the sample without absorption happening.  
IR absorption is related to the vibrational changes that occur inside a molecule when it is 
exposed to infrared radiation.  Essentially infrared spectroscopy can be described as vibrational 
spectroscopy.  Different bonds (C–O, C–C, N–H, C≡C, C=C, C=O and O–H) have different 
vibrational frequencies (Jeffrey et al., 2015; Altermimi et al., 2017).  The presence of these 
bonds in a molecule means that its identification is possible by detecting their unique frequency 
absorption bands in an IR spectrum.  Fourier transform infrared spectroscopy (FTIR) is a high-
resolution analytical tool to identify the functional groups present in a compound (Karimi and 
Taherzadeh, 2016).  FTIR offers a rapid and non-destructive investigation to fingerprint herbal 
extracts or powders. 
Samples for FTIR can be prepared in a number of ways.  For liquid samples, the simplest way 
is to place one drop of sample between two plates of sodium chloride.  The drop forms a thin 
film between the plates.  Solid samples can be milled with potassium bromide (KBr) and then 
compressed into a thin pellet which can be analysed.  Otherwise, solid samples can be dissolved 
in a solvent such as methylene chloride, and the solution then placed onto a single salt plate.  
The solvent is then evaporated off, leaving a thin film of the original material on the plate.  
 
1.7 TOXICITY ASSAYS AND in vivo EVALUATION 
Opoponax essential oil, a chemical component; β-bisabolene and an alcoholic analogue, α-
bisabolol, were tested for selectively kill breast cancer cells by Yeo and co-workers in 2016. It 
was observed that only β-bisabolene, a sesquiterpene constituting 5% of the essential oil, 
exhibited selective cytotoxic activity for mouse cells (IC50) and human breast cancer cells 
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(IC50). This loss of viability was because of the induction of apoptosis. β-bisabolene was also 
effective in reducing the growth of transplanted 4T1 mammary tumours by 37.5% (Yeo et al., 
2016). 
 
1.8 In vitro EVALUATION OF CITRUS FLAVONOIDS 
Meiynanto and co-workers (2012) tested citrus flavonoids for the potential to treat cancer. The 
flavonoids worked either alone or as combination with chemo-preventive agents. The 
mechanisms of action involved but were not limited to cell cycle modulation, apoptosis 
induction and antiangiogenic effects. Naturally occurring compounds were also shown to 
reduce the incidence of resistance and thus increase the efficacy of chemotherapeutics. 
Oestrogen plays a crucial role in the development and differentiation of breast and endometrial 
cells, thus may have certain effects in the growth of cancer. Citrus reticulata ethanolic extract 
was potential to be developed as phytoestrogen as its presence in animal trials shows its ability 
to mimic oestrogens function of strengthening bones and lowering cholesterol levels 
(Meiynanto and Anindyajati, 2012). 
 
1.9 RATIONALE FOR THE STUDY 
The emergence of diseases and drug resistant pathogens coupled with the side effects presented 
by conventional or synthetic drugs necessitates the discovery of new antibiotics, agrochemicals 
and chemotherapeutics.  Kigelia africana fungal endophytes are not well known and thus they 
offer untapped potential for drug discovery.  In 2014, forty endofungal extracts from the Lab 2 
culture collection were previously screened for antimicrobial and antioxidant activity with two, 
namely, ZF 52 and ZF 91, displaying excellent antibacterial activity (minimum inhibitory 
concentrations of 25 and 0.1953 µg/mL, respectively) against a resistant P. aeruginosa strain.  
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The active anti-P. aeruginosa compounds produced by ZF 52 and ZF 91 needed to be purified 
and more K. africana endophytic fungi should be screened for anti-P. aeruginosa activity. 
 
1.10 HYPOTHESIS TESTED 
It was hypothesized that K. africana ZF 52, ZF 91 and other endofungal extracts will display 
antimicrobial activity against P. aeruginosa.  It was further hypothesized that the extracts with 
anti-P. aeruginosa activity could be purified and characterised. 
 
1.11 AIMS AND OBJECTIVES 
The aim of the study was to perform a phytochemical analysis on the medicinal plant species, 
and to test K. africana ZF 52, ZF 91 and other endofungal extracts for antimicrobial activity 
against P. aeruginosa.   
 
 The following objectives were set to test the above hypothesis and achieve the aims of the 
study:  
• To extract biomolecules from endophytic fungal strains, ZF 52, ZF 91 and to screen 
Lab 2 endophytic fungi culture collections for anti-P. aeruginosa activity 
• To induce secondary metabolite production in solid substrate fermentation 
• To obtain concentrated extracts of secondary metabolites in various solvent systems 
• To purify extracts produced by ZF 52, ZF 91 and Lab 2 culture collection using 
preparative thin layer chromatography, bio-autography and column chromatography 
• To characterise the purified anti- P. aeruginosa compound 
To identify the purified compound by Fourier transform infrared spectroscopy (FTIR) and 
nuclear magnetic resonance (NMR) spectroscopy. 
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CHAPTER 2: SCREENING EXTRACTS FOR ANTI- P. aeruginosa ACTIVITY 
 
2.1 INTRODUCTION 
The rise of microbial resistance to antibiotics and the scarcity of new drugs has long been the 
subject of discussion (Theuretzbacher and Mouton, 2011).  The lack of new drug development, 
misuse and overuse has been attributed to the antibiotic resistance crisis (Ventola, 2015).  
Alexander Fleming stated in 1945 that the drug penicillin would be in great demand which 
would lead to an era of antibiotic abuse (Ventola, 2015).  The emergence of resistance is driven 
by three main mechanisms, namely: the rapid increase of antibiotic resistant bacteria due to 
overexposure to antimicrobial compounds or other contaminants (heavy metals and biocides), 
horizontal gene transfer of antibiotic resistance genes and recombination and genetic mutation 
(Berendock et al., 2015).  Acquiring effective, affordable and novel drugs to treat microbial 
infections is a global healthcare challenge but mainly in third world countries where more than 
half of the deaths are due to infectious diseases (Awouafack et al, 2012; Srivastava et al., 2013; 
Elisha et al., 2017).  
It is estimated that 80% of the world’s population relies on herb-based medicine.  Except for 
homeopathy, the healing properties of these plants are evaluated by their chemical composition 
(Ventola, 2015).  Many plants are used in medicine with Indian Ayurveda and the Chinese 
system using roughly 2000 and 5757 plants, respectively (Ventola, 2015).  Similar to Asia, 
Africa is known for its ancient traditional practices and vast number of traditional healers.  Due 
to this, scientists have focused their attention on these plants that have the capacity to heal.  
Plants have the ability to produce a variety of secondary metabolites, for example, tannins, 
alkaloids, flavonoids, glycosides, terpenoids, steroids, quinones, coumarins and saponins (Das 
et al., 2010), which have been the source of antimicrobial substances (Fernebro, 2011; Elisha 
et al., 2017).   
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In the Southern African tropical regions, a commonly encountered medicinal plant is K. 
africana.  All parts of this plant have been used in traditional medicine; the fruit is used to treat 
ulcers, syphilis, abscesses, wounds and rheumatism (Bello et al., 2016).  The bark and roots 
are used to treat pneumonia.  In West Africa, the fruit is used to treat haemorrhoids, dysentery 
and gynaecological disorders.  The traditional medicinal uses of K. africana point to the plants 
potential as a source of antibacterial compounds.  However, there is no scientific research to 
validate its ethnomedicinal use. There have been studies which examined the plant chemistry, 
but these were not been linked with bioactivity studies (Das et al., 2010; Arkhipov et al., 2014; 
Cook and van Vuuren, 2014). Some studies using the bark extracts showed cytotoxity and good 
results in treating renal carcinoma and melanoma (Saini et al., 2009; Arkhipov et al., 2014).  
Different parts of this plant showed growth inhibition against Klebsiela pneumonia, Proteus 
vulgaris, S. aureus, Escherichia coli and P. aeruginosa (Hussain et al., 2016). 
In recent years, focus has shifted to conservation of medicinal plants which has led to the search 
for alternative sources of secondary metabolites (Kusari et al., 2013). Studies on plant 
microbiomes indicated that the plant along with its associated microbiome produces bioactive 
molecules. Investigations of the same plant species located in different geographical regions 
showed that they produced different bioactive metabolites, which suggested that the endophytic 
microorganisms produce the bioactive metabolites and not the plants (Idris et al., 2013; Kusari 
et al., 2013).  Endophytes are bacteria, actinomycetes and fungi that inhabit healthy plants 
without causing them any harm (Das et al., 2017).   
Pseudomonas aeruginosa is the leading cause of infection in hospitalised patients.  It is 
resistant to many antimicrobial agents due to its various resistance mechanisms (Joo et al., 
2011; Nyasulu et al., 2012; Holmes et al., 2016).  The ability of the organism to develop 
additional resistance during treatment further limits treatment (Hancock and Speert, 2000; 
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Mudau et al., 2013).  Risk factors for P. aeruginosa infections include presence of previous 
antibiotic use, admission to an intensive care unit, indwelling devices, prolonged hospital stay, 
pre-existing diseases and an immuno-compromised status (Harris et al., 2002; Joo et al., 2011; 
Mudau et al., 2013).   
A study conducted by Nyasulu et al. (2017) followed the trend of increased P. aeruginosa 
resistance in South African hospitals between 2005 to 2009 and observed a moderate rise in 
resistance for aminoglycosides (gentamicin 21.7% to 53.7%, tobramycin 38.7% to 60.2% and 
25.7% to 39.1% for amikacin), carbapenems (a rise from 45% to 55% for meropenem and 
imipenem), cephalosporins (cefepime 36.6% to 43.6% and 17.1% to 24.6% for ceftazidime) 
and ciprofloxacin (25.9% to 53.7%) (Nyasulu et al., 2017).  The increasing resistance of P. 
aeruginosa to most classes of antibiotics warrants the screening of previously untapped sources 
for anti-P. aeruginosa activity. 
 
2.2 MATERIALS AND METHODS 
2.2.1 Growth and maintenance of cultures 
Endophytic fungal isolates (previously isolated from leaves of K. africana) were obtained from 
the Lab 2 culture collection and sub cultured onto potato dextrose agar (PDA).  The isolates 
were grown for four days at room temperature (RT), stored at 4°C and used as working stocks 
(Strobel and Daisy, 2003).  Pseudomonas aeruginosa ATCC 27853 was sub-cultured from 
stock culture (Dr Chenia, Microbiology Department in UKZN) and grown on Nutrient agar 
(NA) at 37°C for 24 h.  Long-term endofungal stocks were prepared by inoculating spores from 
aged plates into 1.5 mL Eppendorf tubes containing 1 mL of 40% glycerol. Bacterial stocks 
were prepared by growing a loopful of a 24 h plate culture of P. aeruginosa into 3 mL nutrient 
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broth and transferring 0.5 mL of broth culture and 0.5 mL of 40% glycerol into a 1.5 mL 
Eppendorf tube. Both fungal and bacterial stocks were kept at -80°C. 
 
2.2.2 Production of biomolecules   
To induce production of biomolecules, standardised inocula (8 mm blue pipette tip back) from 
PDA plates were inoculated into rice medium (10 g of rice supplemented with 20 mL peptone 
water (0.5% peptone and 0.3% sodium chloride)).  Solid substrate fermentation (SSF) was 
performed at room temperature for 30 days (Talonsi et al., 2012).  In addition, to determine 
optimum time of bioactive molecule production, aliquots of biomass were extracted weekly, 
for four weeks. 
 
2.2.3 Extraction of bioactive molecules 
Bioactive biomolecules were extracted from mycelial mats using ethyl acetate (EtOAc) 
(Prabavathy and Nachiyar, 2014).  To halt the fermentation process, 10 g of the rice medium 
containing the biomass was soaked in 50 mL of EtOAc for 24 h under gentle agitation (100 
rpm, RT).  The biomass and the EtOAc extract were separated by vacuum filtration through 
Whatman No.1 filter paper.  The EtOAc extract containing bioactive compounds was washed 
with 50 mL demineralized water to remove traces of starch.  The organic layers were collected 
and evaporated using a rotary evaporator.  The extract was weighed and resuspended in EtOAc 
to a final concentration of 10 mg/mL and stored in the refrigerator at 4°C until required. 
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2.2.4 Assessing anti-P. aeruginosa activity 
2.2.4.1 Disc diffusion assay 
The test strain used was a multidrug resistant P. aeruginosa ATCC 27853, which is resistant 
to β- lactams, aminoglycosides and fluoroquinolones.  The test bacteria were inoculated onto 
nutrient agar (NA) plates and incubated for 24 h at 37°C.  For a standardised inoculum for the 
disc diffusion assay, culture was inoculated in 500 µL of demineralised water and the cell 
density was standardised to 0.5 McFarland standard using a spectrophotometer (UV 1800). The 
standardised bacterial cells were spread onto Mueller-Hinton (Merck, Germany) plates using 
sterile cotton swabs and left to dry.  Extracts (100 µL) were saturated on sterile filter paper 
discs and used as antibiotic discs.  The plates were incubated at 37°C for 24 h and the resultant 
zones of inhibition were measured and scored according to Table 2.1.  The experiment was 
done in triplicate. 
 
Table 2.1: Scoring of activity of extracts (mm) (Chenia, 2013) 
0-6 7-9 10-15 16-17 ≥18  
No activity No significant 
activity 
Poor activity Good activity Significant 
activity 
 
2.2.4.2 Minimum inhibitory concentration (MIC) determination  
The broth dilution microtitre assay was carried out as described by Kwon et al. (2007) to 
determine the minimum inhibitory concentration (MIC).  The lowest dilution or concentration 
which inhibits growth is the MIC (Kwon et al., 2007; Zin et al., 2007).  The standardised test 
culture inoculum was prepared as described in 2.2.4.1.  The bacterial cells were harvested and 
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standardised to 0.5 McFarland standard in sterile distilled H2O.  A 1:140 dilution of cells was 
made in Muller Hinton (MH) broth (71 µL of standardised cells and 9.929 mL of MH broth).   
Microtitre plates were loaded with the different components as follows: 100 µL of MH broth 
was added into all the wells, an aliquot of 100 µL of extract was added into well one, mixed 
and 100 µL was transferred to well two, and so on until well nine.  The final 100 µL from well 
nine was discarded.  After addition of extracts, 100 µL of the 1:140 diluted cells were added to 
all the wells.  Plates were incubated at 37°C for 24 h.  Thereafter 30 µL resazurin dye was 
added and further incubated at 37°C for 4 h.  Results were read as follows: live cells were pink 
and dead cells were blue.  The highest dilution displaying the blue colour was regarded as the 
MIC. 
2.2.5 Thin layer chromatography  
Crude extract (1 µL) was spotted onto thin layer chromatography (TLC) plates (Merck silica 
gel 60, 20 x 20 cm F254 aluminium sheets: Merck, Germany) and left to develop in various 
solvent systems (Yu et al., 2010).  A solvent system of chloroform (CHCl3):methanol (MeOH) 
and hexane:EtOAc (using 100% CHCl3 or hexane that was increased stepwise by 10% to 100% 
MeOH or EtOAc, respectively) was screened to assess their separation efficiency (Selvameenal 
et al., 2009).  The TLC plates were spotted with the sample using capillary tubes, the plates 
were placed in the solvent mixture in a developing tank and left to run till the solvent front 
reached approximately half a centimetre from the top of the plate.  TLC plates were viewed 
under an ultraviolet lamp (254 nm) and developed using 10% H2SO4 in MeOH (Selvameenal 
et al., 2009). 
2.2.6 Bio-autography 
Agar overlay bio-autography was performed by pouring 10 mL of molten agar seeded with 1 
mL of P. aeruginosa bacterial suspension (0.5 McFarland standard) over the developed 
45 
 
chromatogram and incubating at 37°C for 24 h.  After incubation, all plates were sprayed with 
a 2% (w/v) 2,3,5–triphenyltetrazolium salt stain which stains live cells red (Dewajee et al., 
2015). Clear zones were taken to represent inhibition of growth by anti-P. aeruginosa 
compounds. 
2.2.7 Identification of fungal isolates that produce active compounds of interest 
2.2.7.1. Genomic deoxyribonucleic acid isolation 
Genomic deoxyribonucleic acid (DNA) isolation was conducted using the ZR Soil Microbe 
DNA MiniprepTM (Zymo Research, USA) according to the manufacturer’s instructions.  After 
extraction, the DNA was analysed by agarose gel electrophoresis.  DNA samples were stored 
at -20°C.  
2.2.7.2 Amplification of internal transcribed spacer two region 
The universal primers for the fungal internal transcribed spacer two (ITS2) region of the 18S 
ribonucleic acid (rRNA) gene were used in the PCR reaction (White et al., 1990; Ristaino et 
al., 1998).  The ITS primer pair sequences were as follows: 
Forward: ITS 5 (5' – GGAAGTAAAAGTCGTAACAAGG – 3')  
Reverse: ITS 4 (5' – TCCTCCGCTTATTGATATGC – 3')  
The PCR reaction mixture (50 µL) consisted of template DNA, 2.5 µM of each of the forward 
and reverse primers, 25 mM MgCl2, 10 mM dNTPs, Taq DNA polymerase, 10 mM buffer 
(Thermo Scientific).  The reaction mixture was brought to 50 µL using double distilled water.  
Amplification of the reaction mixture was conducted under the following thermal cycling 
conditions:  initial denaturation at 94°C for 5 min, 30 cycles of denaturation at 94°C for 30 s, 
annealing at 55°C for 30 s and extension at 72°C for 30 s (Anderson et al., 2003). 
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2.2.7.3. Sequencing of ITS2 region 
The PCR products were visualised using electrophoretic analysis on a 1% agarose gel stained 
with ethidium bromide.  After confirmation that the amplification was successful, amplicons 
were sequenced using Sanger sequencing at Stellenbosch University, South Africa. The 
identity of the isolates was determined using the basic local alignment search tool (BLAST) 
analysis, using the NCBI database (Anderson et al., 2003). 
 
2.3 RESULTS 
2.3.1 Growth and maintenance of cultures 
Potato dextrose agar plates were used to successfully resuscitate thirty-three endophytic fungi 
as the grown fungi matched the original isolates in terms of varying characteristics and 
pigmentation.  The pigmentation of the mycelia intensified with age from lightly pigmented as 
the mycelia grew into fresh media (Fig 2.1).  This was observed for all fungi growing on PDA.  
 
 
 
Figure 2.1: Growth of endophytic fungi on potato dextrose agar media for 4 days. A and B: show ZF 
52 and ZF 53 fungal isolates (top and bottom); C and D: show KZ 81 and ZF KZ 44. 
 
 A  B 
 C  D 
A 
A
A 
 C 
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2.3.2 Production of biomolecules 
The solid substrate fermentation reaction contents showed varying pigmentation where initial 
growth was observed on day four of the 30-day period for fast growing fungi and as delayed 
as day 15 for slow growing fungi.  The presence of white fluffy growths on the surface of the 
solid substrate was common in all the fermentation vessels.  Pigmentation developed with time 
as observed in Figure 2.2.  A characteristic of most of the fermenting biomass was that it 
matched the pigment observed on PDA plates, with one exception namely ZF 52, which was 
black and yellow on PDA and black in SSF.   
 
Figure 2.2: Development of mycelial mat growth during the SSF.  A: ZF 52, B: ZF 53. 
2.3.3 Extraction of bioactive molecules 
An assortment of pigments was observed after solvent extraction.  The pigmentation of the 
extracts mostly matched the pigments of the biomass on the PDA plates and SSF reaction 
vessels, with the exception of ZF 52 whose extract matched only the growth on PDA and not 
during SSF (Fig 2.3). 
 A  B 
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Figure 2. 3: Endophytic fungi extracts obtained following solvent extraction. 
 
2.3.4 Assessing anti-P. aeruginosa activity 
2.3.4.1 Disc diffusion assay 
Variable results were obtained using the disc diffusion assay for the 45 extracts.  Most extracts 
did not inhibit P. aeruginosa, while a few (three) had significant activity (Figure 2.4 A and B).  
The size of the zones of inhibition depicted good activity of the extracts.  ZF 52 displayed the 
largest zone of inhibition (40 mm) for T4.  Zones of inhibition obtained differed from extract 
to extract and these ranged from 0-40 mm.  ZF 52, ZF 91 and ZF 34 had very good activity, 
however, due to difficulties encountered in resuscitating long-term cultures from storage, ZF 
91 and ZF 34 were not tested further resulting in ZF 52 being the only fungal extract tested 
further.  A time course was conducted in order to observe the difference in activity from week 
one to week four.  The bioactive compounds are produced as early as week as seen in Fig 2.4 
C.  
   
49 
 
 
Figure 2.4: Kirby Bauer disc diffusion assay demonstrating anti-P. aeruginosa activity of ethyl acetate 
extracts of endophytic fungi; A: ZF 34 and B: KZ 81, KZ 43, KZ 31 and KZ 78. 
 
 
Figure 2.5: Kirby Bauer disc diffusion assay demonstrating anti-P. aeruginosa activity of ZF 52 extracts 
after varying fermentation periods. A1 indicates ZF 52 extract produced after one (T1) and two (T2) 
weeks and A2 indicates ZF 52 extracts produced after three (T3) and four (T4) weeks.  
  
2.3.4.2 MIC determination  
Minimum inhibitory concentrations were determined for those extracts with large inhibition 
zones, namely, the ZF 52 extracts produced after varying periods of solid substrate 
fermentation (T1 to T4) (Figure 2.6).  All rows A, B, C and D show very strong activity. Extract 
T4 displayed the strongest activity (lowest MIC) against P. aeruginosa while the one with the 
weakest activity (highest MIC) was T1.  The crude extracts developed greater antimicrobial 
activity over time; the MICs of the extracts were 156.5 µg/mL, 39.06 µg/mL, 78.73 µg/mL and 
19.53 µg/mL for T1, T2, T3 and T4, respectively. 
 A  B 
 A2  A1 
B 
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Figure 2.6: Resazurin colour reaction for minimum inhibitory concentration (µg/mL) determination of 
extracts against P. aeruginosa. Row A: 1 week ZF 52 extract 156.3; row B: 2 week ZF 52 extract 39.06; 
row C: 3 week old ZF 52 extract 78.13 and row D is a 4 week old ZF 52 extract 19.53.  
Table 2. 2: Interpretation of the resazurin microtitre assay 
Extract Concentration (µg/mL) 
1          2         3         4         5           6          7           8            9           10          11          12 
 5000 2500 1250 625 312.5 156.3 78.13 39.06 19.53 9.766 4.883 2.441 
T1 - - - - - - + + + + + + 
T2 - - - - - - - - + + + + 
T3 - - - - - - - + + + + + 
T4 - - - - - - - - - + + + 
Keys: +: growth; -: no growth 
2.3.5 Thin layer chromatography 
All the solvents tested resulted in separation of the different compounds in the crude extract. 
CHCl3 and EtOAc resulted in little separation of the different compounds in the extract (Figure 
2.7 A), with smears being observed.  Figure 2.7 B shows better separation resulting from TLC 
using hexane and EtOAc.  Figure 2.8 C showed the separating of the time-course extracts when 
viewed under UV light.  The compound with Rf values around 0.78 was produced from the 
first week.  On the second week the band begins to separate, and the band is seen slightly higher 
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than the one at T1.  Better separation and more compounds are observed from week three while 
the four-week-old extract shows that the compounds become more concentrated.  The 
compounds within ZF 52 crude extract are really produced from the first week of SSF, this 
corroborates Figure 2.5. 
 
Figure 2. 7: TLC analysis of ZF 52 crude ethyl acetate extracts; separated using (A) CDCl3:EtOAc 
(60:40). A - ZF 52 at four week ethyl acetate extract viewed with staining; (B) - ZF 52 separation using 
chloroform:ethyl acetate (Rf: 0.22, 0.30, 0.34, 0.43, 0.57 and 0.78) without staining (60:40). 
 
 
Figure 2.8: TLC analysis ZF 52 crude ethyl acetate extracts of varying ages separated using 
hexane:EtOAC and viewed under UV.  T1- one week old; T2- two week old; T3- three week old and 
T4 is a four week old ZF 52 ethyl acetate extract. 
 
2.3.6 Bio-autography 
Bio-autography revealed that the majority of the compounds resolved on the TLC plates 
contained bactericidal activity as three (Rf: 0.22, 0.30 and 0.78) bands produced halos after the 
 A  B  
 T1     T2       T3     T4 
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dye was sprayed (Figure 2.9). However, the bands close to the origin had no bactericidal 
activity because these bands appeared pink.  
 
Figure 2. 9: Bio-autogram of P. aeruginosa treated ZF 52 extract. Live cells appear pink and dead cells 
are presented by a halo. A - bio-autogram; B - TLC plate. 
 
2.3.7 Identification 
2.3.7.1 Genomic DNA isolation 
It was extremely difficult to lyse the mycelia of ZF 52.  Poor yields of genomic DNA were 
obtained after several attempts of using aged mycelia. In the final attempt, a 24 h culture was 
manually disrupted using forceps.  The resultant small mycelia were then subjected to bead 
bashing as per kit instruction manual but the vortexing time was increased from 30 s to 60 s.  
A barely visible yield of genomic DNA was obtained visualised on an agarose gel which was 
stained with ethidium bromide (Figure 2.10).                                                                   
           1     2     3 
 
 
 
 
Figure 2. 10:  Genomic DNA isolated from ZF 52 on agarose gel. L1: 100 bp plus marker, L2 and L3: 
ZF52 DNA. 
 Genomic DNA 
A 
A
A
A 
B  
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2.3.7.2 PCR amplification 
Figure 2.11 shows the gel image of the PCR product obtained after amplification of the ITS2 
region of the 18S rRNA gene.  The PCR amplification was successful as the expected amplicon 
size of 600 bp was obtained.                                                                 
            
 
 
 
Figure 2.11:  Agarose gel image of the ITS2 region of18S rRNA gene after PCR amplification. L1: 100 
bp Gene ruler, L2: PCR amplification product, L3: negative control. 
 
2.3.7.3 Identification of ZF52 
The 18S PCR amplicon was sequenced at Stellenbosch University, South Africa. Trimmed 
forward and reverse sequences were aligned and submitted to Genbank for comparison to other 
sequences. The result returned from Genbank showed ZF 52 has 99% identity to 
Neofusicoccum luteum strain CMW 10309 (Table 2.3).  
 
Table 2.3: BLAST analysis of ZF 52 
Description Max 
score 
Total 
score 
Query 
cover 
E 
value 
Identity Accession 
Neofusicoccum luteum strain 
CMW 10309 18S ribosomal RNA 
gene, partial sequence: internal 
transcribed spacer 1.5 ribosomal 
1070 1070 99% 0.0 99% KF766202.
1 
 
 600 bp 
 800 bp 
1         2        3 
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2.4 DISCUSSION 
Resuscitation of the fungal endophytes from stock cultures was successful as morphology and 
pigmentation matched the original plates. Darkly pigmented medicinal plant extracts are 
reported in literature to possess strong bioactive activity; these include but are not limited to 
anti-HIV, antimalarial, antimicrobial, antioxidant and anticancer properties. The darkly 
pigmented endophytic extracts had no activity against P. aeruginosa as all three darkly 
pigmented extracts did not produce zones of inhibition.  A study by Sharma et al. (2016) 
described a fungus with olive green pigmentation with extracts containing bioactive 
metabolites further suggesting that dark pigmented fungi that produce dark extracts are the 
most likely to contain bioactive metabolites.  
 
In the current study, however, the darkly pigmented endophytic extracts had no activity against 
P. aeruginosa as all three darkly pigmented extracts did not produce zones of inhibition. 
However, ZF 52, ZF 91 and ZF 34, which were lightly pigmented had good activity against P. 
aeruginosa contrary to Sharma et al. (2016).  No two extracts had the same colour.  It is 
tempting to assume that they were produced by different fungal species or different strains of 
the same endophytic fungus as some of the fungi had the same pigmentation and colony 
morphology.  This may be confirmed by identifying all the isolates.   
 
In the antimicrobial activity testing, it was observed that most of the extracts had little to no 
activity against P. aeruginosa.  In a previous study, it was observed that K. africana endophytic 
fungal extracts had antimicrobial activity mainly against fungi (Kuali, 2015, Shezi, 2014).  This 
could be because within K. africana, beneficial and pathogenic fungi compete for nutrients and 
shelter thus resulting in fungal endophytes being able to kill most fungi.  Out of the 45 extracts 
screened, only three namely ZF 52, ZF 91 and ZF 34 displayed activity against multi drug 
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resistant P. aeruginosa strain (with 40.33, 22 and 20 mm diameter zones of inhibition, 
respectively).  A study by Ratnaweera and co-workers (2015) also reported variable zones of 
inhibition (8 to 35 mm) against three Gram-positive bacteria, Bacillus subtilis (UBC 344), 
Staphylococcus aureus (ATCC 43300) and MRSA (ATCC33591), two Gram-negative 
bacteria, Escherichia coli (UBC 8161), P. aeruginosa (ATCC 27853) and the pathogenic 
fungus Candida albicans (ATCC 90028).  They screened eight endofungal extracts from the 
arid zone invasive plant Opuntia dillenii and only two produced zones of inhibition above 30 
mm.  However, none of these extracts were active against P. aeruginosa.   
Phenolics, alkaloids and terpenes are the most encountered antibacterial compounds found in 
medicinal plants and it would be no surprise if the extracts from ZF 52, ZF 91 and ZF 34 also 
contain these compounds (Chandra et al., 2017).  Prabukumar et al. (2015) tested endophytic 
fungi CC1, CC2, CC3 and CC4 isolated from Crescentia cujete for antibacterial activity.  These 
were evaluated against Gram-negative bacteria Salmonella typhi (ATCC 51812), Shigella 
flexneri (MTCC 1457), Enterococcus faecalis (ATCC 29212), Klebsiella pneumoniae (ATCC 
432), P. aeurginosa (ATCC-27853), E. coli (ATCC-25922) and Gram-positive bacteria B. 
subtilis (ATCC 441), S. aureus (ATCC 25923).  These extracts displayed good activity against 
bacterial human pathogens, in general. Strain CC1 and CC3 crude extracts displayed 
intermediate inhibition activity against all the human pathogens except P. aeurginosa and S. 
aureus while the crude extract of CC4 also inhibited all these human pathogens except for S. 
aureus.  The extract of CC2 inhibited the growth of S. typhi and Shigella sp. The MeOH and 
EtOAc fungal crude extracts of endophytic fungus Pestalotiopsis neglecta BAB-5510 isolated 
from the leaves of Cupressus torulosa inhibited the growth of both Gram-negative and Gram-
positive bacterial human pathogens (Sharma et al., 2016).  These had activity against S. aureus, 
B. subtilis, S. typhimurium and E. coli. However, they displayed no activity against P. 
aeruginosa.  
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Thin layer chromatography was conducted using several solvent systems before the one giving 
optimal separation was identified. The most efficient solvent system was hexane:EtOAC 
(60:40) and it resulted in six distinct spots with Rf values of (0.22, 0.30, 0.34, 0.43, 0.57 and 
0.78).  In a study conducted by Rashid et al. (2017), various solvent systems were utilised with 
the most effective one being toluene:EtOAC:acetic acid (36:12:5) which resulted in five spots 
which had Rf values of 0.4, 0.45, 0.46, 0.55, 0.82.  Sharma et al. (2016) also used TLC to 
separate the different compounds from the crude extract of P. niglecta and the solvent system 
with optimal resolution was dichloromethane:MeOH (90:10). This yielded two distinct bands 
with the second band (Rf of 0.79) displaying antibacterial activity. 
Antibacterial components were present in the EtOAC extract (Figure 2.9).  This was consistent 
with a study conducted by Jesionek et al. (2017) where halos were observed on the bio-
autogram against several bacterial test strains. The bio-autogram in the current study showed 
more than one spot of the developed TLC plate to have anti-P. aeruginosa activity.  Live cells 
were seen close to the origin and on the fifth spot indicating that four out of five spots possessed 
anti-Pseudomonas activity.  A study by Samrot et al. (2016) that utilised TLC and bio-
autography to screen extracts from Mangifera indica observed a band (Rf of 0.82) that 
displayed anti-P. aeruginosa activity which is not frequently encountered, and which was 
contrary to the current study.  However, in their study, they used a different dye, namely, the 
MTT dye instead of the 2% (w/v) 2,3,5–triphenyltetrazolium dye.  Methanolic extracts of 
Ricinus communis were used to conduct bio-autography with P. aeruginosa (PC 002) and K. 
pneumoniae (MTCC 3384) as the test cultures (Sandam and Su, 2015).  For P. pneumoniae 
four active bands were observed in total for the fractions with Rf values: 0.200, 0.2750, 0.8875 
and 0.9125.  One active band with Rf value 0.2750 was observed for P. aeruginosa.  The 
methanolic extracts of R. communis displayed more activity against K. pneumoniae than P. 
aeruginosa. 
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Sequencing and BLAST analysis of the ITS2 amplicon of ZF 52 had 99% identity to 
Neofusicoccum luteum strain CMW 10309.  This fungus was previously identified by Shezi in 
2014, this therefore means that culture storage and maintenance, resuscitation and biomolecule 
production was successful for ZF 52 but was unsuccessful for ZF 91 and ZF 34.  Sharma et al. 
(2016) studied the endophytic fungi associated with the Cupressus torulosa.  Five fungi were 
isolated and identified as Alternaria alternata, Penicillium oxalicum, Daldinia sp. and 
Pestalotiopsis sp.  Idris et al. (2013) isolated seven endophytic fungi and identified them as 
Aspergillus flavus, Aspergillus sp., Cladosporium sp., Culvularia lunata and three unknown 
fungi.  A study by Maheswari and Rajagopal (2013) identified 28 endophytic fungi, none of 
which was N. luteum.  In contrast Wicaksono et al. (2017) isolated N. luteum from plants as a 
pathogen which was inhibited by endophytic Pseudomonas sp.  The P. aeruginosa endophyte 
was reported to produce diffusible and volatile compounds which inhibited the growth of six 
botryosphaeriaceous species including N. luteum, which is the opposite to the findings of the 
current study.  These finding from these two studies clearly points out the shifting nature of 
plant-fungal relationships that depend on the balance of antagonism – the interplay of plant, 
fungal, other organisms and environmental factors (Kusari et al., 2012).  
 
2.5 CONCLUSION 
Three extracts out of the 45 tested, displayed activity against P. aeruginosa.  Although the 
proportion of active to inactive fungal extracts was low, the ones with activity had very 
significant activity.  ZF 91 and ZF 34 were not tested further as resuscitation and storage 
difficulties were encountered. Separation of ZF 52 revealed the extract to contain more than 
one compound and the compounds present were shown to have antibiotic activity as 80% of 
the spots showed anti-Pseudomonas activity.  The fungus, N. luteum, and the subsequent 
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extract that it produces are not well known, this therefore justifies this study.  These findings 
promote the purification and further testing the of N. luteum extract. 
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CHAPTER 3: PURIFICATION AND CHARACTERISATION OF THE 
Neofusicoccum luteum ANTI-P. aeruginosa COMPOUND FROM THE ETHYL 
ACETATE CRUDE EXTRACT  
 
3.1 INTRODUCTION 
Endophytic Botryosphaeriaceae species have been reported to be in high abundance and 
encountered very frequently and research has targeted their potential as producers of novel 
secondary metabolites with anticarcinogenic, antibiotic and fungicidal activity (Saikkonen, 
2002; Garcia et al., 2012; Dos Santos et al., 2016). However, the extent to which some of these 
species might be considered true endophytes or pathogens undergoing a latent phase still 
remains in question (Reveglia et al., 2018). 
Neofusicoccum luteum host colonisation and infection happens mostly through horizontal 
transmission (individual infections via conidia or ascospores), although vertical transmission 
(infection through seeds) has been reported (Slippers et al., 2013; Lopes et al., 2016).  Within 
the plant, species of this genus are able to exist without causing any symptoms and thus remain 
in the plant as endophytes.  The endophytism of Neofusicoccum sp. could be the crucial feature 
aiding their wide distribution since they can be moved effortlessly around the world in cuttings, 
seeds and also in fruits, subsequently infecting both native and non-native trees in their new-
found environments (Lopes et al., 2016).  Neofusicoccum luteum is a plant pathogen and causes 
dieback and canker in grapevines and tomato cuttings (Altermimi et al., 2017; Rezgui et al., 
2018).   
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Isolation and purification of bioactive compounds is a technique that has undergone new 
developments in recent years (Altemimi et al., 2015; Atlermimi et al., 2017; Kanagavalli and 
Sadiq, 2018).  The technique provides concise separation, isolation and purification and offers 
an abundance of advanced bioassays (Poongunran et al., 2016).  When looking for bioactive 
compounds, the goal is to find an appropriate method to screen the extracts for antimicrobial, 
antioxidant and or cell toxicity in conjunction with simplicity, speed and specificity (Eruygur 
et al., 2016; Altermimi et al., 2017).  
 
Numerous bioactive molecules have been separated and purified by thin-layer and column 
chromatographic methods (Devika and Koilpillai, 2015).  These chromatographic methods are 
still the mostly used due to their affordability, convenience and availability. Alumina, cellulose, 
silica and polyamide are the most important materials when separating separating plant-based 
compounds (Kangavalli and Sadiq, 2018).  Using multiple mobile phases to increase polarity 
is very important for high value separations.  Heteronuclear Multiple Bond Correlation 
(HMBC) experiment correlates chemical shifts of two types of nuclei separated from each other 
with two or more chemical bonds while the Distortionless enhancement by polarization transfer 
(DEPT) experiment is able to fully separate the carbon signals. DEPT 45 yields CH, CH2 and 
CH3 signals positive, DEPT 90 yields only CH signals and DEPT 135 yields CH and CH3 
positive while CH2 s negative (Kangavalli and Sadiq, 2018). 
Due to the promising results obtained in Chapter 2 regarding the crude extract of N. luteum, 
the fungus N. luteum being relatively undocumented and the extract it produces being 
unknown, the aim herein was to purify and characterise the anti-P. aeruginosa compound. 
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3.2 MATERIALS AND METHODS 
3.2.1 Activity-based purification by column chromatography  
A glass column was prepared for silica gel gravity chromatography.  The column was rinsed 
with hexane (reagent grade, Merck, India) and left to dry.  A cotton plug was placed at the base 
of the column to prevent the silica from leaking.  Activated silica gel (60 mesh, Sigma Aldrich, 
Switzerland) was then packed into the glass column (length: 53 cm and width: 15 cm) with 
hexane (Kaur et al., 2015).  Rotary evaporation was used to concentrate the N. luteum crude 
extract (2 g) which was then mixed with the silica gel in a ratio of 1:1 and loaded into the 
column.  
Optimal separation of compounds was already obtained in 2.3.5.  The EtOAc extract (2 g) was 
subjected to column chromatography with hexane:EtOAc as the mobile phase, starting with 
100% hexane.  The polarity of the solvent system was gradually increased by 5% for every 100 
mL until 100% EtOAc was reached.  The polarity of the mobile phase was further increased 
with 5 and 10% MeOH, sequentially.  A total of 27 fractions were collected and combined into 
four fractions, namely, A (1 – 10, 230 mg), B (11-16, 310 mg), C (17-21, 150 mg) and D (22-
27, 310 mg), based on similarities in the TLC profiles of the fractions.  The four fractions were 
further processed by TLC, TLC-bioautography and MIC determinations as described in 2.2.5, 
2.2.6 and 2.2.4.2, respectively.  
3.2.2 Nuclear magnetic resonance (NMR)  
From the MIC determinations conducted on the four fractions, it was observed that only 
fraction C displayed anti- P. aeruginosa activity, thus this fraction was subjected to further 
purification.  Fraction C afforded compound 1 upon crystallization from ethanol.  The isolate 
was dissolved in deuterated chloroform (CDCl3) and subjected to 1 and 2D NMR spectroscopy.  
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3.3 RESULTS  
3.3.1. Purification by activity-based fractionation of the anti-P. aeruginosa compound  
Column chromatography, bioautographic detection and MIC assays were utilised to purify the 
anti-P. aeruginosa compound of interest.  Fractions A-D were subjected to TLC and TLC-
bioautography for detection.  Smudged spots (no clear bands) were observed from TLC (Figure 
3.2) and TLC-bioautography that yield inconclusive results. This was not repeated due to lack 
of sample; however, MIC determinations were conducted to determine if fractions contained 
anti-P. aeruginosa activity.  The MIC results revealed fraction C to be the only fraction with 
activity against P. aeruginosa with an MIC of 2.441 µg/mL (Figure 3.3).  Further purification 
of Fraction C using column chromatography yielded compound 1 with an MIC of 0.6104 
µg/mL (Figure 3.4). 
 
 
Figure 3. 1: Thin layer chromatography of fractions A, B, C and D. 
 
                                                      1      2       3      4      5      6     7      8      9    10     11    12 
 
Figure 3. 2: Broth microtitre serial dilution assay (µg/mL) for MIC determination of partially purified 
pooled fractions.  Wells 1-10 contain cells, Muller Hinton broth and sample; Well 11 contains 8% 
DMSO in water and Well 12 contains more media as a replacement for extract. 
 
  A            B           C             D 
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Table 3.1: Interpretation of the resazurin microtitre assay for Fraction C 
Concentration (µg/mL) 
1          2           3            4          5           6          7           8            9           10          11          12 
312.5 156.3 78.13 39.06 19.53 9.766 4.883 2.441 1.221 0.6103 0.3051 0.1521 
- - - - - - - - + + + + 
Keys: +: growth -: no growth 
 
                                                   
 
1       2        3       4      5       6       7      8      9      10     11    12 
 
Figure 3. 3: Broth microtitre serial dilution assay (µg/mL) for MIC determination for purified compound 
1. Wells 1-10 contain cells, Muller Hinton broth and sample; Well 11 contains 8% DMSO in water and 
Well 12 contains more media as a replacement for extract. 
 
Table 3.2: Interpretation of the resazurin microtitre assay for compound 1 
Concentration (µg/mL) 
1            2           3            4            5           6            7           8            9           10            11          12 
9.766 4.883 2.441 1.221 0.6103 0.3051 0.1521 0.0761 0.0380 0.0190 0.010 0.0048 
- - - - - + + + + + + + 
Key: +: growth; -: no growth 
3.3.2 Nuclear magnetic resonance and structure elucidation 
Compound 1: HR-ESI-MS: m/z 297.1109 [M+Na]+, (calcd for C16H18O4Na, 297.1103). IR 
(KBr) νmax cm-1: 2926, 2879, 1771, 1702, 1612, 1466, 1384, 1200, 1034, 878. 1H NMR (CDCl3, 
400 MHz): ẟH: 6.18 (1H, m, H-7), 5.73 (1H, d, J = 1.52 Hz, H-11), 5.00 (1H, brt, J = 4.52 Hz, 
H-6), 4.96 (1H, dt, J = 13.57 Hz, H-13a), 4.87 (1H, d, J = 13.57 Hz, H-13b), 2.24 (1H, ddd, J 
= 13.71, 7.66, 5.64 Hz, H-3a), 1.92 (1H, d, J = 4.66 Hz, H-5) (Figure 3.5 A and B), 1.72 – 1.58 
 Compound 1 
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(3H, overlapping multiplets, H-1a, 1b, 2b), 1.53 (1H, ddd, J = 14.28, 7.45, 6.06 Hz, H-3b), 1.30 
(3H, s, H-15), 1.15 (3H, s, H-16) (Figure 3.6).  
13C NMR (CDCl3, 400 MHz): ẟC: 180.8 (C-14), 163.6 (C-12), 158.7 (C-9), 132.2 (C-8), 121.8 
(C-7), 111.7 (C-11), 71.3 (C-6), 69.5 (C-13), 47.8 (C-5), 42.7 (C-4), 35.0 (C-10), 29.6 (C-1), 
27.7 (C-3), 24.7 (C-16), 24.1 (C-15), 17.3 (C-2) (Figure 3.7).   
A total of sixteen peaks, comprising two methyl, four methylene, four methine and six 
quaternary carbons were observed in the 13C NMR spectrum (Figure 3.7) and the Distortionless 
enhancement by polarization transfer (DEPT) spectra (Figure 3.8) supported these findings. 
The HMBC spectrum showed 3J correlation between carbonyl at C-11 with methylene protons 
H-8, methine proton H-10 and methyl protons H-16; and carbonyl at C-2 with H-1b and H-3 
(Figure 3.9). 1H NMR was conducted on fraction 17 and compound 1 was isolated as a white 
solid from the extract of the fungus N. luteum with a molecular formula C16H18O4 (Figure 3.10).  
 
Figure 3.4: H NMR spectrum of compound 1 in CDCl3. 
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Figure 3.5: Expanded 1H NMR spectrum of compound 1 in CDCl3 (A and B). 
 
Figure 3.6: 13C NMR spectrum of compound 1 in CDCl3. 
 
70 
 
Figure 3.7: DEPT spectra of compound 1. 
 
Figure 3.8: HMBC spectrum of compound 1. 
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Figure 3.9: Major HMBC correlations observed in compound 1. 
3.4 DISCUSSION 
Analysis by TLC of these four fractions yielded inconclusive results and forced early MIC 
determination. The MIC determination showed only fraction C to possess bioactive metabolites 
which were able to kill P. aeruginosa (Figure 3.3). Fraction C was therefore purified and 
yielded a white crystalline substance, compound 1 (35 mg) which accounted for 1.75% of the 
crude extract (2 g).   
The MIC obtained for compound 1 was exceptional at 0.6103 µg/mL (Figure 3.4) indicating 
that the pure compound is more active than the partially purified extract (2.441 µg/mL in Figure 
3.3) and crude extracts (19.53 µg/mL as seen in Figure 2.6) that contain a range of compounds.  
A similar study by Fall et al. (2017) using an ethanol extract of Aphania senegalensis resulted 
in antibacterial activity against S. aureus, E. coli and E. faecalis with MICs of 0.31 mg/mL, 
0.16 mg/mL and 0.08 mg/mL respectively.  However, the extract did not show growth 
inhibition against P. aeruginosa. In addition, a study by Malhadas et al. (2017) on the 
antibacterial activity of the EtOAc and MeOH extracts of Alterneria alternata fungus showed 
the extracts to have activity against several bacteria with MICs ranging between 0.095 and 25 
mg/mL. The EtOAc extract of the fungus gave an MIC value of 3.125 mg/mL against P. 
aeruginosa, which was higher than the current study.  These comparisons indicate that activity 
of the extracts of N. luteum against P. aeruginosa is encouraging. 
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The 1H NMR spectrum (Figure 3.5) showed characteristic alkenyl resonances at ẟH 6.18 (H-7) 
and 5.73 (H-11) which were confirmed by the 13C NMR chemical shifts at ẟC 121.8 and 111.7, 
respectively. Oxygenated methine (ẟH 5.00) and methylene (ẟH 4.96 & 4.87) protons were 
assigned to H-6 and H-13a&b, respectively, while the corresponding oxygenated methine and 
methylene carbons were observed at ẟC 71.3 (C-6) and 69.5 (C-13), respectively.  The 16 peaks 
observed in Figure 3.7 were also observed by the DEPT spectra (Figure 3.8). Two of the 
quaternary carbons (ẟC 180.8 and 163.6) were ester carbonyl carbons which confirm the 
dilactone nature of compound 1 (Figure 3.10).   
The locations of the angular methyl protons and the proximity of double bonds to rings B and 
C were confirmed using HMBC correlations (Figure 3.10) which were deduced from the 
HMBC spectrum presented in Figure 3.9. There was a correlation between H-11 and the ring 
C carbonyl. H-13 had correlations with C-12, C-9 and C-7 while the correlation of H-5 to C-
14 carbonyl confirms the fusion of ring D with rings A and B. The NMR analysis, supported 
by the vibrational frequencies (cm-1) of C=O (1771, 1702), C-O (1034), C=C (1612) and C-H 
(2926) using FTIR justify compound 1 as a dilactone. The dilactone was confirmed with an 
exact mass m/z 297.1109 for C16H18O4Na.  Thus, the molecular formula of compound 1 was 
deduced to be C16H18O4.  
Compound 1 (C16H18O4) was identified as a dilactone (3a,10b-dimethyl-1,2,3,3a,5a,7,10b,10c-
octahydro-5,8-dioxa-acephenanthrylene-4,9-dione) and it matched compound 3 in the study of 
antineoplastic agents conducted by Pettit et al. (2003).  The same compound was synthesised 
from a Wieland-Miescher ketone and was similar to oidiolactone C (C16H18O5) (Hanessian et 
al., 2009).  This compound occurs both naturally and synthetically. The compound was also 
tested for antibacterial and antifungal activity against S. aureus, Shigella dysenteriae, 
Penicillium avellaneum, C. albicans and Saccharomyces cerevisiae.  It displayed anti-C. 
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albicans, anti-S. cerevisiae and anti-P. avellaneum activity but no antibacterial activity (Lin et 
al., 2009).  This suggests that existing compounds (synthetic and natural) need to be tested for 
new properties as none of the oidiolactones have displayed activity against resistant P. 
aeruginosa in the past. 
Oidiolactones were first reported by John et al. (1999).  The filamentous fungi represented by 
Oidiodendron truncatum and Oidiodendron griseum produced the tetranorditerpenoid 
dilactone, oidiolactones A-D. These were shown to display bioactive properties similar to those 
produced by cladosporin, a known antifungal, antibacterial and insecticide compound 
(Hanessian et al., 2009).   
 
3.5 CONCLUSION 
The purification and characterisation of N. luteum ethyl acetate crude extract was successful 
and proved that the purer a crude extract is; the more antimicrobial activity it possesses.  This 
could be due to antagonistic effects of inactive compounds present in the crude extract. The 
compound isolated from the ethyl acetate extract of N. luteum showed good anti-P. aeruginosa 
activity and this is a step in the right direction in treating infections caused by P. aeruginosa. 
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CHAPTER 4: SUMMARY, CONCLUSIONS AND RECOMMENDATIONS FOR 
FUTURE WORK 
4.1 SUMMARY OF FINDINGS 
Plate stocks and mineral oil slants for endophytic storage are more efficient than glycerol stocks 
as plate stocks and mineral oil slants stocks resulted in fungal resuscitation with no 
contamination as opposed to glycerol stocks.  Phenotypic traits of the endophytic fungi change 
slightly in response to being sub-cultured from different stocks over time. Due to fungal 
extracts being diverse and relatively untested for optimal time for the production of the 
bioactive compound, it was crucial to set up a time course in order to identify this for the anti-
P. aeruginosa bioactive compound.  Although the compound appears within one week of 
growth, maximal levels were produced at 4 weeks of growth. Over the various intervals of 
growth tested, the profiles of compounds varied. 
It was important to assess the effect of purification on the anti-P. aeruginosa activity of the 
compound.  Crude extracts contain a variety of compounds which either act together to have a 
combined effect, act against each other or each compound may have entirely different 
activities.  Literature reports that bioactivity increases with purity due to the desired compound 
being present in higher concentrations and with no impurities.  It needs to be noted that some 
studies have reported purification to have the opposite effect due to the compounds found in 
the crude extract acting synergistically.  Thus, the purer the compound was, the more reduced 
its ability to inhibit a test organism was.  
Isolation of the active metabolite from the crude extract and characterisation showed the 
compound to be a dilactone (3a,10b-dimethyl-1,2,3,3a,5a,7,10b,10c-octahydro-5,8-dioxa-
acephenanthrylene-4,9-dione) which displayed anti-P. aeruginosa activity against a resistant 
strain.  This has been a new approach in using this compound which was previously reported 
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to display antifungal activity and inhibit both lipopolysaccharide-induced interleukin- lj8 and 
tumour necrosis factor-α production in human whole blood.   
4.2 CONCLUSIONS 
The aim of this study was to purify, identify and characterise ZF 52 and other K. africana 
endophytic fungi against P. aeruginosa which was a relatively new approach.  When 
comparing the MIC of the crude, semi-purified and purified extract, the MIC of the purified 
extract had the most anti-P. aeruginosa activity.  Characterisation and identification were 
successful and achieved by NMR spectroscopy. The isolated bioactive metabolite from the 
extract of N. luteum was identified as a dilactone (3a,10b-dimethyl-1,2,3,3a,5a,7,10b,10c-
octahydro-5,8-dioxa-acephenanthrylene-4,9-dione).  As purification of the N. luteum extract 
was successful, the hypotheses were accepted.  Although the isolated compound is not novel 
and has previously been shown to have activity against some fungal species, its ability to inhibit 
the growth of P. aeruginosa to this degree is new. This suggests that known compounds need 
to be screened across a wide range of pathogens and organisms to determine potential activity. 
 
4.3 RECOMMENDATIONS FOR FUTURE WORK 
With the vast amount and rapid emergence of bacterial resistance to antibiotics, more testing 
of the anti-P. aeruginosa compound would help reduce the speed at which this pathogen gains 
resistance.  Although the anti-P. aeruginosa activity was determined against one resistant strain 
of P. aeruginosa, in order to conclusively realise the activity of this compound it be tested 
against as many different resistant strains as possible as well as against any clinical strains with 
emerging resistance.   
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Column chromatography was used as a purification method, for future studies it may be 
beneficial to use prep-HPLC for purification as higher yields and greater purity of the purified 
product are reported to be obtained using this technique.  The purified compound 1 isolated in 
this study is a known diterpene lactone that was first isolated from a marine sponge and 
demonstrated to have antifungal activity (John et al., 1999). This finding highlights the fact 
that bioactive compounds need to be screened against a wide a panel as possible in order to 
properly determine their bioactive potential.  A compound previously shown to have activity 
against one pathogen needs to be screened against a wide range of other pathogens, especially 
newly developing resistant strains, as a potential drug candidate may already be available, but 
its full spectrum not yet elucidated, and screening would provide a more rapid solution as the 
compound has already been purified and identified.   
The determination of the mode of action (assessing membrane integrity) using a capturing 
confocal scanning laser microscope is also an important factor and next step in the process  in 
deciding whether or not a compound will be taken to the next level of testing (pre-clinical 
screening and testing) and if the compound still looks promising, safety and efficacy clinical 
trials, as well as drug development, formulation  and production. 
Interdisciplinary research involving Microbiology, Animal biology and Chemistry is key in 
fast tracking future drug development. This is because different disciplines have access to 
different materials. It would be interesting to investigate anti-cancer and a- diabetic activities, 
however the Microbiology department does not have a tissue culture lab for anti-cancer 
determination, nor does it supply mice for anti-diabetic trails. 
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APPENDICES 
 
APPENDIX A 
Table A1: Growth of K. africana endophytic fungi on PDA. 
ISOLATE Morphology 
KZ 
52 
 
 
 
 
Top 
Brown centre with 
outward expansion. 
Green with a cream edge. 
Bottom 
Cream with light bottle 
green 
 
 
KZ 
34 
  
Top  
Green of varying 
intensity as mycelia 
expand 
Bottom 
Navy centre, green 
expansion and white 
edge 
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KZ 
73 
 
 
 
 
Top 
Different shades of green 
and is lightest in the 
centre, with white edge 
Bottom 
Green with a white edge 
KZ 
79 
  
Top 
Green, with the lightest 
shade at the centre 
Bottom 
Black with light green to 
white edge 
KZ 
81 
 
 
Top 
Red with white woolly 
matter 
Bottom 
Brown centre with red 
carcadia 
KZ 
72 
 
 
 
 
Top 
Green with white edge 
Bottom 
Yellow, darkest at the 
centre, with black 
extremities 
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KZ 
54 
 
 
 
 
Top 
Light green with faint 
green extremity 
Bottom 
White and snotty looking 
KZ 
49 
 
 
 
 
Top 
Black, which changes to 
green as it spreads out 
Bottom 
Black at the centre and 
becomes lighter as fungi 
expands                                                   
KZ 
44 
 
 
 
 
Top 
Light green with white 
fluff  
Bottom 
Intense yellow and 
expands to be light 
yellow 
KZ 
22 
 
 
 
 
Top 
White fluff 
Bottom 
White centre, growing 
towards the ends with 
black dots/spores 
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KZ 
43 
 
 
 
 
Top 
Light brown with white 
fluff growing on the 
surface 
Bottom 
Yellow with circular 
yellow rings which 
become less intense 
KZ 
38 
 
 
 
 
Top 
Oldest part of the 
mycelia is bottle green 
and becomes faints green 
as it spreads out  
Bottom 
Pale green as it spreads to 
fresh medium, becomes 
intense green as it ages  
KZ 
74 
 
 
 
 
Top  
Light green at the centre 
which becomes darker as 
it grows out 
Bottom 
White at the centre which 
becomes darker as it 
grows outward 
KZ 
78 
 
 
 
 
Top 
Green centre with white 
fluff as it grows away 
from the centre 
Bottom 
Black with green and 
white colouration 
85 
 
ZF 
91 
  
Top 
Black inoculum plug 
which spreads to be 
white 
Bottom 
Becomes white as it 
spreads to fresh media. 
The oldest part is black 
ZF 
65 
 
 
 
 
Top  
Oldest part is black, 
spreads to be green. Has 
whooly fluff covering it 
Bottom 
Bottle green centre, with 
darker edges 
ZF 
79 
 
 
 
 
Top 
Black with white fluff 
covering the surface 
Bottom 
Black centre, becomes 
orange as it spreads 
ZF 
69 
 
 
 
 
Top 
Green centre and grows 
to have fluff at the 
extremities 
Bottom 
Intense orange centre  
and turns yellow as it 
grows in fresh media 
86 
 
ZF 
88 
 
 
 
 
Top 
White centre which 
spreads to be ivory 
Bottom 
Pale brown centre which 
Grows pale yellow  
ZF 
68 
 
 
 
 
 
Top 
Black centre which 
spreads to be yellow 
Bottom 
Green and spreads  
ZF 
84 
 
 
 
 
Top 
Yellow at the centre and 
spreads to have white 
fluff 
Bottom  
Black initial growth at 
the centre and spreads to 
be pale yellow 
 
ZF 
59 
 
 
 
 
Top 
The centre has green 
growth at the centre 
Bottom 
Black centre and grows 
yellow as it spreads to 
fresh media 
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ZF 
53 
 
 
 
 
Top 
Orange at the centre, 
becomes white as it 
spreads to fresh media 
Bottom 
Intense orange centre and 
white edges 
ZF 
96 
  
Top 
Ivory centre with off-
white extremities 
Bottom 
Ivory centre with  
ZF 
66 
 
 
 
 
Top 
Black centre, spreads 
white 
Bottom 
Brown centre, which 
spreads ivory 
ZF 
52 
 
 
 
 
Top 
Black centre, spreads 
yellow and white at the 
extremities 
Bottom 
Black with yellow edges 
88 
 
ZF 
58 
 
 
 
 
Top 
Ivory centre, which 
spreads white 
Bottom 
Ivory and becomes white 
with fresh media 
ZF 
55 
 
 
 
 
Top 
Black centre, spreads 
green into fresh media 
Bottom 
Bottle green centre, 
becomes less intense 
green as it spreads to 
fresh media 
ZF  
82 
 
 
 
 
Top  
Green centre, becomes 
yellow as it grows on 
fresh media 
Bottom 
Black centre with new 
mycelia appearing yell-
ow 
 
ZF 5 
  
Top 
Mycelia looks green and 
turns black as it ages 
Bottom 
Black with ivory edges 
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APPENDIX B 
P. aeruginosa 
  
 
 
        
Figure B1.1: Kirby Bauer disc diffusion assay showing zones of inhibition by K. africana endofungal 
extracts 
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Figure B1.2: Kirby Bauer disc diffusion assay of Lab 2 extract stocks. 
 
Table B1: Raw data from the Kirby Bauer disc diffusion assay for initial screening of extracts 
 Zone of inhibition (mm) Avg STD 
ZF52 42 40 39 40,33333 1,080123 
ZF34 22 19 20 20,33333 1,080123 
ZF91   20 25 20 22 2.357023 
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  A  
  B  
Figure B2: Resazurin colour reaction for MIC determination; A: ZF 52 and B: ZF 91. 
 
Of the screened isolates ZF91, ZF52 and ZF 34 revealed anti-P. aeruginosa compounds of 
interest, however when ZF 91 was sub-cultured from stocks it did not grow and ZF34 was a 
lab isolate extract and the stock culture wasn’t found.  Therefore, ZF 52 was the only fungal 
isolate used for further testing. 
 
APPENDIX C 
Table C1: Growth of ZF 52 endophytic fungus on PDA. 
Fungal isolate Morphology 
  
Top 
Older mycelia look black, as it 
grows on new media it turns 
cream/light yellow 
Bottom 
Black centre with new mycelia 
being yellow 
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    A  
   
   B      
Figure C1: Kirby Bauer disc diffusion assay showing zones of inhibition produced by ZF 52 
endofungal extracts against P. aeruginosa.  A (T1 and T2) and B (T3 and T4). 
 
 
Table C2: Raw data from the Kirby Bauer disc diffusion assay of the time course extracts. 
Extract 
(days) 
Triplicate 
1 
Triplicate 
2 
Triplicate 
3 
Average Standard 
deviation 
T1 14 17 15 15,33333 1,080123 
T2 28 27 27 27,33333 0,408248 
T3 25 18 28 23,66667 3,62859 
T4 42 40 39 40,33333 1,080123 
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Figure C2: Resazurin colour reaction for MIC determination of extracts against P. aeruginosa. 
Row A: 1 week ZF 52 extract (156.3 µg/mL); row B: 2 weeks ZF 52 extract (39.06 µg/mL); 
row C: 3 weeks old ZF 52 extract (78.13 µg/mL) and row D is 4 weeks old ZF 52 extract (19.53 
µg/mL). 
Table C3: Interpretation of the resazurin microtitre assay. 
Extract 
age 
Concentration (µg/mL) 
 5000 2500 1250 625 312.5 156.3 78.13 39.06 19.53 9.766 4.883 2.441 
T1 - - - - - - + + + + + + 
T2 - - - - - - - - + + + + 
T3 - - - - - - - + + + + + 
T4 - - - - - - - - - + + + 
 
Identification of ZF 52  
Sequencing data:  
GGGKACTGCGGAGATCATTACCGAGTTGATTCGAGCTCCGGCTCGACTCTCCCAC
CCTATGTGTACCTACCTCTGTTGCTTTGGCGGGCCGCGGTCCTCCGCACCGGCGC
CCTTCGGGGGGCTGGCCAGCGCCCGCCAGAGGACCATAAAACTCCAGTCAGTGA
ACTTCGCAGTCTGAAAAACAAGTTAATAAACTAAAACTTTCAACAACGGATCTCT
TGGTTCTGGCATCGATGAAGAACGCAGCGAAATGCGATAAGTAATGTGAATTGC
AGAATTCAGTGAATCATCGAATC 
 
Table C4: BLAST analysis of ZF 52. 
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APPENDIX D 
 
Figure D1.1: Thin layer chromatography of crude ethyl acetate extract chloroform:ethyl acetate. 
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Figure D1.2: Thin layer chromatography of crude ethyl acetate extract chloroform:ethyl acetate stained 
with 5% methanol in sulphuric acid. 
 
         
Figure D2: Thin layer chromatography of ethanol and methanol extracts using chloroform:Methanol. 
 
 
Figure D3: Thin layer chromatography of ZF 52 ethyl acetate extract using acetonitryl:ethyl acetate 
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Figure D4: Thin layer chromatography of ZF 52 ethyl acetate extract using hexane:ethyl acetate 
A  B  
Figure D5: (A)Thin layer chromatography and (B) bioautography of the ZF 52 crude extract. 
 
APPENDIX E 
A  B  
Figure E1: Thin layer chromatography of partially purified extract, with sub-fractions A, B, C and D. 
 
   
Figure E2: Broth microtitre serial dilution assay for MIC determination of partially purified purified 
pooled fractions C   
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Figure E3: Broth microtitre serial dilution assay for MIC determination for purified compound 1.  
 
 
APPENDIX F 
 
Figure F1: 1H-NMR (chloroform d1, MHz) of compound 1. 
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Figure F2: 1H-NMR (chloroform d1, MHz) of compound 1 (A and B). 
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Figure F3: 13C-NMR of bioactive fraction compound 1. 
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Figure F4: 13C Dept 90 and Dept 135 of bioactive fraction superimposed. 
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Figure F5: 1H- 13C HMBC NMR spectrum of compound 1. 
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Figure F6: COSY 1H-NMR spectrum of fraction compound 1. 
 
Figure F7: HSQC NMR spectrum of compound 1. 
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Figure F8:  2-D NOESY spectrum of compound 1. 
 
 
 
 
 
 
Figure F9: Major HMBC correlations observed in compound 1. 
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Figure F10: FTIR spectrum of compound 1. 
 
APPENDIX G 
Table G1: Crystal data and structure refinement for 18zs_bm_s1_0ma.  
Table G1: Crystal data and structure refinement for 18zs_bm_s1_0ma.  
Identification code  18zs_bm_s1_0ma  
Empirical formula  C16H18O4  
Formula weight  274.30  
Temperature/K  100  
Crystal system  monoclinic  
Space group  C2  
a/Å  18.120(3)  
b/Å  7.6922(13)  
c/Å  12.393(4)  
α/°  90  
β/°  129.372(6)  
γ/°  90  
Volume/Å3  1335.3(5)  
107 
 
Z  4  
ρcalcg/cm3  1.364  
μ/mm-1  0.097  
F(000)  584.0  
Crystal size/mm3  0.29 × 0.18 × 0.11  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  4.252 to 56.676  
Index ranges  -24 ≤ h ≤ 24, -10 ≤ k ≤ 10, -16 ≤ l ≤ 16  
Reflections collected  16326  
Independent reflections  3281 [Rint = 0.0458, Rsigma = 0.0296]  
Data/restraints/parameters  3281/1/183  
Goodness-of-fit on F2  1.061  
Final R indexes [I>=2σ (I)]  R1 = 0.0387, wR2 = 0.1015  
Final R indexes [all data]  R1 = 0.0407, wR2 = 0.1032  
Largest diff. peak/hole / e Å-3  0.40/-0.23  
Flack parameter 0.2(3) 
 
Table G2: Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement Parameters. 
Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for 18zs_bm_s1_0ma. Ueq is defined as 1/3 of of the trace of the 
orthogonalised UIJ tensor. 
Atom x y z U(eq) 
O4 6223.6(11) -2781(2) 6527.3(17) 27.5(4) 
O3 7745.1(10) -2460.1(18) 8450.4(15) 21.4(3) 
O2 10496.6(10) 2835.2(19) 12525.0(15) 21.4(3) 
O1 10445.4(11) 5510(2) 11854.1(16) 26.3(3) 
C11 6970.5(14) -2024(3) 7120(2) 20.0(4) 
C9 7233.6(13) -609(3) 6558(2) 18.6(4) 
C10 8087.3(13) 215(2) 7927.9(19) 15.8(4) 
C5 7797.6(13) 1635(3) 8484.6(19) 17.1(4) 
C4 8730.7(13) 2177(3) 9861(2) 17.3(4) 
C3 9070.0(14) 3800(2) 10260(2) 19.0(4) 
C2 10033.9(14) 4140(3) 11588(2) 20.1(4) 
C12 8553.2(14) -1345(2) 8899(2) 18.5(4) 
C8 6433.4(14) 659(3) 5494(2) 22.2(4) 
C7 6323.6(14) 2332(3) 6060(2) 24.1(4) 
C6 7271.0(14) 3051(3) 7367(2) 22.1(4) 
C15 7155.5(14) 993(3) 8826(2) 20.9(4) 
C14 9293.6(13) 745(2) 10840.0(19) 17.5(4) 
C13 9174.9(13) -904(3) 10421(2) 18.3(4) 
C1 9957.9(14) 1298(3) 12341(2) 20.5(4) 
C16 7562.4(15) -1609(3) 5847(2) 24.7(4) 
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Table G3: Anisotropic Displacement Parameters (Å2×103) for 18zs_bm_s1_0ma. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Anisotropic Displacement Parameters (Å2×103) for 18zs_bm_s1_0ma. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
O4 22.4(7) 29.3(8) 33.1(8) -2.6(6) 18.8(7) -7.2(6) 
O3 20.6(7) 20.2(7) 25.9(7) 0.5(6) 15.9(6) -2.2(5) 
O2 18.0(7) 21.7(7) 22.6(6) -1.4(5) 12.0(6) -1.6(5) 
O1 23.5(7) 22.6(7) 30.5(7) -2.6(6) 16.1(6) -3.7(6) 
C11 21.2(9) 18.8(8) 26.5(9) -2.0(7) 18.1(8) -1.0(7) 
C9 16.7(9) 22.7(10) 20.9(9) -1.4(7) 14.1(8) -1.6(7) 
C10 14.5(8) 18.6(8) 19.5(8) -0.3(7) 13.2(7) -0.6(7) 
C5 15.0(8) 17.9(8) 21.4(9) 1.2(7) 12.9(8) 0.9(7) 
C4 16.4(8) 20.8(9) 21.1(8) 0.3(7) 15.0(7) 1.4(7) 
C3 18.0(9) 19.1(9) 23.6(9) 0.4(7) 14.9(8) 1.7(7) 
C2 20.6(9) 21.7(9) 24.3(10) -2.5(8) 17.2(8) 0.0(8) 
C12 17.1(8) 18.5(8) 24.2(9) 0.0(7) 15.1(8) -0.1(7) 
C8 19.5(9) 26(1) 21.5(9) 2.7(8) 13.2(8) 1.6(8) 
C7 18.0(9) 24.5(9) 24.6(9) 2.8(8) 11.1(8) 2.3(8) 
C6 20.4(9) 19.4(9) 25.0(9) 3.3(8) 13.6(8) 2.5(7) 
C15 17.2(9) 26(1) 25.2(9) -1.1(8) 16.0(8) -0.3(7) 
C14 14.8(8) 21.6(9) 21.0(8) 1.3(7) 13.7(7) 0.3(7) 
C13 16.3(8) 20.3(9) 22.6(9) 3.4(7) 14.4(8) 1.8(7) 
C1 19.6(9) 22.9(9) 21.3(8) 0.5(8) 14.1(8) -1.1(7) 
C16 22.5(10) 32.5(11) 25.1(9) -5.8(8) 18.0(8) -1.0(8) 
  
Table G4: Bond Lengths for 18zs_bm_s1_0ma. 
Bond Lengths for 18zs_bm_s1_0ma. 
Atom Atom Length/Å   Atom Atom Length/Å 
O4 C11 1.204(3)   C5 C4 1.511(3) 
O3 C11 1.366(2)   C5 C6 1.529(3) 
O3 C12 1.469(2)   C5 C15 1.550(3) 
O2 C2 1.350(2)   C4 C3 1.340(3) 
O2 C1 1.456(2)   C4 C14 1.468(3) 
O1 C2 1.210(3)   C3 C2 1.477(3) 
C11 C9 1.523(3)   C12 C13 1.499(3) 
C9 C10 1.531(3)   C8 C7 1.538(3) 
C9 C8 1.539(3)   C7 C6 1.533(3) 
C9 C16 1.546(3)   C14 C13 1.336(3) 
C10 C5 1.550(3)   C14 C1 1.500(3) 
C10 C12 1.520(3)         
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Table G5: Bond Angles for 18zs_bm_s1_0ma. 
Bond Angles for 18zs_bm_s1_0ma. 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
C11 O3 C12 109.14(15)   C15 C5 C10 114.98(16) 
C2 O2 C1 118.69(15)   C3 C4 C5 126.65(18) 
O4 C11 O3 120.98(19)   C3 C4 C14 118.57(17) 
O4 C11 C9 128.6(2)   C14 C4 C5 114.77(17) 
O3 C11 C9 110.33(16)   C4 C3 C2 121.19(18) 
C11 C9 C10 100.26(15)   O2 C2 C3 118.48(18) 
C11 C9 C8 116.55(16)   O1 C2 O2 118.31(17) 
C11 C9 C16 104.52(17)   O1 C2 C3 123.13(19) 
C10 C9 C8 115.32(16)   O3 C12 C10 103.99(15) 
C10 C9 C16 110.76(15)   O3 C12 C13 112.41(16) 
C8 C9 C16 108.75(16)   C13 C12 C10 114.46(16) 
C9 C10 C5 113.32(15)   C7 C8 C9 117.64(16) 
C12 C10 C9 102.35(15)   C6 C7 C8 113.69(17) 
C12 C10 C5 112.25(15)   C5 C6 C7 109.69(16) 
C4 C5 C10 104.15(14)   C4 C14 C1 113.75(17) 
C4 C5 C6 115.72(17)   C13 C14 C4 122.34(18) 
C4 C5 C15 106.03(15)   C13 C14 C1 123.80(18) 
C6 C5 C10 106.96(15)   C14 C13 C12 120.76(18) 
C6 C5 C15 109.20(16)   O2 C1 C14 110.82(16) 
  
Table G6: Torsion Angles for 18zs_bm_s1_0ma. 
Torsion Angles for 18zs_bm_s1_0ma. 
A B C D Angle/˚   A B C D Angle/˚ 
O4 C11 C9 C10 159.3(2)   C4 C3 C2 O2 -12.9(3) 
O4 C11 C9 C8 34.1(3)   C4 C3 C2 O1 163.9(2) 
O4 C11 C9 C16 -85.9(3)   C4 C14 C13 C12 8.7(3) 
O3 C11 C9 C10 -24.4(2)   C4 C14 C1 O2 -47.5(2) 
O3 C11 C9 C8 -149.55(17)   C3 C4 C14 C13 -159.64(19) 
O3 C11 C9 C16 90.41(18)   C3 C4 C14 C1 24.1(2) 
O3 C12 C13 C14 -118.8(2)   C2 O2 C1 C14 43.1(2) 
C11 O3 C12 C10 20.64(19)   C12 O3 C11 O4 179.32(18) 
C11 O3 C12 C13 145.00(17)   C12 O3 C11 C9 2.7(2) 
C11 C9 C10 C5 -86.00(18)   C12 C10 C5 C4 61.39(19) 
C11 C9 C10 C12 35.10(17)   C12 C10 C5 C6 -175.61(15) 
C11 C9 C8 C7 91.0(2)   C12 C10 C5 C15 -54.2(2) 
C9 C10 C5 C4 176.73(15)   C8 C9 C10 C5 40.0(2) 
C9 C10 C5 C6 -60.3(2)   C8 C9 C10 C12 161.13(16) 
C9 C10 C5 C15 61.2(2)   C8 C7 C6 C5 -54.1(2) 
C9 C10 C12 O3 -35.00(17)   C6 C5 C4 C3 10.0(3) 
C9 C10 C12 C13 -158.03(16)   C6 C5 C4 C14 -171.15(16) 
C9 C8 C7 C6 33.3(2)   C15 C5 C4 C3 -111.2(2) 
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C10 C9 C8 C7 -26.2(2)   C15 C5 C4 C14 67.6(2) 
C10 C5 C4 C3 127.1(2)   C15 C5 C6 C7 -58.2(2) 
C10 C5 C4 C14 -54.1(2)   C14 C4 C3 C2 6.6(3) 
C10 C5 C6 C7 66.8(2)   C13 C14 C1 O2 136.24(19) 
C10 C12 C13 C14 -0.4(3)   C1 O2 C2 O1 169.16(18) 
C5 C10 C12 O3 86.82(17)   C1 O2 C2 C3 -13.9(2) 
C5 C10 C12 C13 -36.2(2)   C1 C14 C13 C12 -175.40(17) 
C5 C4 C3 C2 -174.61(17)   C16 C9 C10 C5 164.06(16) 
C5 C4 C14 C13 21.4(3)   C16 C9 C10 C12 -74.84(19) 
C5 C4 C14 C1 -154.89(16)   C16 C9 C8 C7 -151.27(18) 
C4 C5 C6 C7 -177.67(17)             
  
 
Table G7: Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for 18zs_bm_s1_0ma. 
Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters (Å2×103) 
for 18zs_bm_s1_0ma. 
Atom x y z U(eq) 
H10 8534.62 721.69 7798.21 19 
H3 8683.59 4749.02 9677.96 23 
H12 8948.36 -1970.02 8716.33 22 
H8A 6537.25 998.96 4828.79 27 
H8B 5820.34 21.03 4956.59 27 
H7A 6014.79 3230.62 5320.78 29 
H7B 5895.88 2093.87 6282.03 29 
H6A 7670.96 3450.62 7127.97 27 
H6B 7147.19 4058.29 7729.51 27 
H15A 6580.78 445.15 7997.27 31 
H15B 6972.35 1983.45 9108.79 31 
H15C 7507.41 145.45 9588.83 31 
H13 9488.3 -1808.37 11095.01 22 
H1A 9585.47 1553.5 12655.52 25 
H1B 10405.25 337.9 12921.88 25 
H16A 8042.21 -2476.07 6495.48 37 
H16B 7840.3 -791.1 5585.95 37 
H16C 7013.12 -2193.22 5008.32 37 
Experimental  
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Figure G1: Single-crystal X-ray structure and numbering scheme of compound 1. 
 
 
Figure G2: Structure of CJ-14445. 
